id	sid	tid	token	lemma	pos
gra-1905	1	1	introduction	introduction	NOUN
gra-1905	1	2	chronic	chronic	ADJ
gra-1905	1	3	obstructive	obstructive	ADJ
gra-1905	1	4	pulmonary	pulmonary	ADJ
gra-1905	1	5	disease	disease	NOUN
gra-1905	1	6	is	be	AUX
gra-1905	1	7	a	a	DET
gra-1905	1	8	common	common	ADJ
gra-1905	1	9	,	,	PUNCT
gra-1905	1	10	preventable	preventable	ADJ
gra-1905	1	11	and	and	CCONJ
gra-1905	1	12	treatable	treatable	ADJ
gra-1905	1	13	disease	disease	NOUN
gra-1905	1	14	that	that	PRON
gra-1905	1	15	is	be	AUX
gra-1905	1	16	characterized	characterize	VERB
gra-1905	1	17	by	by	ADP
gra-1905	1	18	persistent	persistent	ADJ
gra-1905	1	19	respiratory	respiratory	ADJ
gra-1905	1	20	symptoms	symptom	NOUN
gra-1905	1	21	and	and	CCONJ
gra-1905	1	22	airow	airow	NUM
gra-1905	1	23	limitation	limitation	NOUN
gra-1905	1	24	that	that	PRON
gra-1905	1	25	is	be	AUX
gra-1905	1	26	due	due	ADJ
gra-1905	1	27	to	to	ADP
gra-1905	1	28	airway	airway	NOUN
gra-1905	1	29	and	and	CCONJ
gra-1905	1	30	/	/	SYM
gra-1905	1	31	or	or	CCONJ
gra-1905	1	32	alveolar	alveolar	ADJ
gra-1905	1	33	abnormalities	abnormality	NOUN
gra-1905	1	34	usually	usually	ADV
gra-1905	1	35	caused	cause	VERB
gra-1905	1	36	1by	1by	ADJ
gra-1905	1	37	signicant	signicant	ADJ
gra-1905	1	38	exposure	exposure	NOUN
gra-1905	1	39	to	to	ADP
gra-1905	1	40	noxious	noxious	ADJ
gra-1905	1	41	particles	particle	NOUN
gra-1905	1	42	or	or	CCONJ
gra-1905	1	43	gases	gas	NOUN
gra-1905	1	44	.	.	PUNCT
gra-1905	2	1	the	the	DET
gra-1905	2	2	term	term	NOUN
gra-1905	2	3	chronic	chronic	ADJ
gra-1905	2	4	systemic	systemic	ADJ
gra-1905	2	5	inammatory	inammatory	ADJ
gra-1905	2	6	syndrome	syndrome	NOUN
gra-1905	2	7	is	be	AUX
gra-1905	2	8	proposed	propose	VERB
gra-1905	2	9	to	to	PART
gra-1905	2	10	take	take	VERB
gra-1905	2	11	account	account	NOUN
gra-1905	2	12	of	of	ADP
gra-1905	2	13	inammatory	inammatory	ADJ
gra-1905	2	14	nature	nature	NOUN
gra-1905	2	15	of	of	ADP
gra-1905	2	16	copd	copd	PROPN
gra-1905	2	17	and	and	CCONJ
gra-1905	2	18	its	its	PRON
gra-1905	2	19	co	co	ADJ
gra-1905	2	20	morbid	morbid	NOUN
gra-1905	2	21	conditions	condition	NOUN
gra-1905	2	22	such	such	ADJ
gra-1905	2	23	as	as	ADP
gra-1905	2	24	mets	met	NOUN
gra-1905	2	25	metabolic	metabolic	NOUN
gra-1905	2	26	syndrome	syndrome	NOUN
gra-1905	2	27	has	have	VERB
gra-1905	2	28	.	.	PUNCT
gra-1905	3	1	multiple	multiple	ADJ
gra-1905	3	2	risk	risk	NOUN
gra-1905	3	3	factors	factor	NOUN
gra-1905	3	4	that	that	PRON
gra-1905	3	5	arise	arise	VERB
gra-1905	3	6	from	from	ADP
gra-1905	3	7	insulin	insulin	NOUN
gra-1905	3	8	resistance	resistance	NOUN
gra-1905	3	9	accompanying	accompany	VERB
gra-1905	3	10	abnormal	abnormal	ADJ
gra-1905	3	11	adipose	adipose	ADJ
gra-1905	3	12	deposition	deposition	NOUN
gra-1905	3	13	and	and	CCONJ
gra-1905	3	14	function	function	NOUN
gra-1905	3	15	.	.	PUNCT
gra-1905	4	1	it	it	PRON
gra-1905	4	2	is	be	AUX
gra-1905	4	3	a	a	DET
gra-1905	4	4	risk	risk	NOUN
gra-1905	4	5	factor	factor	NOUN
gra-1905	4	6	for	for	ADP
gra-1905	4	7	coronary	coronary	ADJ
gra-1905	4	8	heart	heart	NOUN
gra-1905	4	9	disease	disease	NOUN
gra-1905	4	10	,	,	PUNCT
gra-1905	4	11	diabetes	diabetes	NOUN
gra-1905	4	12	,	,	PUNCT
gra-1905	4	13	fatty	fatty	NOUN
gra-1905	4	14	liver	liver	NOUN
gra-1905	4	15	,	,	PUNCT
gra-1905	4	16	and	and	CCONJ
gra-1905	4	17	several	several	ADJ
gra-1905	4	18	cancers	cancer	NOUN
gra-1905	4	19	.	.	PUNCT
gra-1905	5	1	obesity	obesity	NOUN
gra-1905	5	2	is	be	AUX
gra-1905	5	3	seen	see	VERB
gra-1905	5	4	in	in	ADP
gra-1905	5	5	approximately	approximately	ADV
gra-1905	5	6	18	18	NUM
gra-1905	5	7	%	%	NOUN
gra-1905	5	8	of	of	ADP
gra-1905	5	9	patients	patient	NOUN
gra-1905	5	10	with	with	ADP
gra-1905	5	11	copd	copd	PROPN
gra-1905	5	12	and	and	CCONJ
gra-1905	5	13	is	be	AUX
gra-1905	5	14	far	far	ADV
gra-1905	5	15	more	more	ADV
gra-1905	5	16	common	common	ADJ
gra-1905	5	17	in	in	ADP
gra-1905	5	18	early	early	ADJ
gra-1905	5	19	stages	stage	NOUN
gra-1905	5	20	2(stage	2(stage	NOUN
gra-1905	5	21	-	-	PUNCT
gra-1905	5	22	i	i	PROPN
gra-1905	5	23	and	and	CCONJ
gra-1905	5	24	ii	ii	NOUN
gra-1905	5	25	)	)	PUNCT
gra-1905	5	26	.	.	PUNCT
gra-1905	6	1	3,4several	3,4several	NUM
gra-1905	6	2	studies	study	NOUN
gra-1905	6	3	from	from	ADP
gra-1905	6	4	north	north	PROPN
gra-1905	6	5	america	america	PROPN
gra-1905	6	6	have	have	AUX
gra-1905	6	7	shown	show	VERB
gra-1905	6	8	a	a	DET
gra-1905	6	9	prevalence	prevalence	NOUN
gra-1905	6	10	of	of	ADP
gra-1905	6	11	metabolic	metabolic	NOUN
gra-1905	6	12	syndrome	syndrome	NOUN
gra-1905	6	13	in	in	ADP
gra-1905	6	14	copd	copd	NOUN
gra-1905	6	15	patients	patient	NOUN
gra-1905	6	16	in	in	ADP
gra-1905	6	17	a	a	DET
gra-1905	6	18	5range	5range	NUM
gra-1905	6	19	29	29	NUM
gra-1905	6	20	-	-	SYM
gra-1905	6	21	58	58	NUM
gra-1905	6	22	%	%	NOUN
gra-1905	6	23	.	.	PUNCT
gra-1905	7	1	tanni	tanni	PROPN
gra-1905	7	2	et	et	PROPN
gra-1905	7	3	al	al	PROPN
gra-1905	7	4	reported	report	VERB
gra-1905	7	5	mets	met	NOUN
gra-1905	7	6	in	in	ADP
gra-1905	7	7	36	36	NUM
gra-1905	7	8	%	%	NOUN
gra-1905	7	9	of	of	ADP
gra-1905	7	10	copd	copd	NOUN
gra-1905	7	11	patients	patient	NOUN
gra-1905	7	12	.	.	PUNCT
gra-1905	8	1	indian	indian	ADJ
gra-1905	8	2	data	datum	NOUN
gra-1905	8	3	on	on	ADP
gra-1905	8	4	the	the	DET
gra-1905	8	5	prevalence	prevalence	NOUN
gra-1905	8	6	of	of	ADP
gra-1905	8	7	mets	met	NOUN
gra-1905	8	8	or	or	CCONJ
gra-1905	8	9	its	its	PRON
gra-1905	8	10	6components	6component	NOUN
gra-1905	8	11	in	in	ADP
gra-1905	8	12	copd	copd	NOUN
gra-1905	8	13	are	be	AUX
gra-1905	8	14	sparse	sparse	ADJ
gra-1905	8	15	.	.	PUNCT
gra-1905	9	1	dave	dave	PROPN
gra-1905	9	2	et	et	PROPN
gra-1905	9	3	al	al	PROPN
gra-1905	9	4	reported	report	VERB
gra-1905	9	5	mets	met	NOUN
gra-1905	9	6	in	in	ADP
gra-1905	9	7	42	42	NUM
gra-1905	9	8	%	%	NOUN
gra-1905	9	9	copd	copd	NOUN
gra-1905	9	10	cases	case	NOUN
gra-1905	9	11	.	.	PUNCT
gra-1905	10	1	the	the	DET
gra-1905	10	2	aim	aim	NOUN
gra-1905	10	3	of	of	ADP
gra-1905	10	4	this	this	DET
gra-1905	10	5	study	study	NOUN
gra-1905	10	6	was	be	AUX
gra-1905	10	7	to	to	PART
gra-1905	10	8	investigate	investigate	VERB
gra-1905	10	9	the	the	DET
gra-1905	10	10	prevalence	prevalence	NOUN
gra-1905	10	11	mets	met	NOUN
gra-1905	10	12	in	in	ADP
gra-1905	10	13	stable	stable	ADJ
gra-1905	10	14	copd	copd	NOUN
gra-1905	10	15	patients	patient	NOUN
gra-1905	10	16	.	.	PUNCT
gra-1905	11	1	methods	method	NOUN
gra-1905	11	2	this	this	DET
gra-1905	11	3	prospective	prospective	ADJ
gra-1905	11	4	study	study	NOUN
gra-1905	11	5	was	be	AUX
gra-1905	11	6	conducted	conduct	VERB
gra-1905	11	7	in	in	ADP
gra-1905	11	8	67	67	NUM
gra-1905	11	9	copd	copd	NOUN
gra-1905	11	10	patients	patient	NOUN
gra-1905	11	11	attending	attend	VERB
gra-1905	11	12	the	the	DET
gra-1905	11	13	department	department	NOUN
gra-1905	11	14	of	of	ADP
gra-1905	11	15	tuberculosis	tuberculosis	NOUN
gra-1905	11	16	and	and	CCONJ
gra-1905	11	17	respiratory	respiratory	ADJ
gra-1905	11	18	diseases	disease	NOUN
gra-1905	11	19	,	,	PUNCT
gra-1905	11	20	g.s.v.m	g.s.v.m	PROPN
gra-1905	11	21	.	.	PROPN
gra-1905	11	22	medical	medical	PROPN
gra-1905	11	23	college	college	PROPN
gra-1905	11	24	,	,	PUNCT
gra-1905	11	25	kanpur	kanpur	PROPN
gra-1905	11	26	from	from	ADP
gra-1905	11	27	april2017	april2017	PROPN
gra-1905	11	28	to	to	ADP
gra-1905	11	29	march	march	PROPN
gra-1905	11	30	-2018	-2018	PROPN
gra-1905	11	31	.	.	PUNCT
gra-1905	12	1	inclusion	inclusion	NOUN
gra-1905	12	2	criteria	criterion	NOUN
gra-1905	12	3	:	:	PUNCT
gra-1905	12	4	ÿ	ÿ	DET
gra-1905	12	5	stable	stable	ADJ
gra-1905	12	6	copd	copd	NOUN
gra-1905	12	7	patients	patient	NOUN
gra-1905	12	8	.	.	PUNCT
gra-1905	13	1	exclusion	exclusion	NOUN
gra-1905	13	2	criteria	criterion	NOUN
gra-1905	13	3	:	:	PUNCT
gra-1905	13	4	ÿ	ÿ	ADP
gra-1905	13	5	other	other	ADJ
gra-1905	13	6	respiratory	respiratory	ADJ
gra-1905	13	7	diseases	disease	NOUN
gra-1905	13	8	such	such	ADJ
gra-1905	13	9	as	as	ADP
gra-1905	13	10	pulmonary	pulmonary	ADJ
gra-1905	13	11	tuberc	tuberc	ADJ
gra-1905	13	12	ulosis	ulosis	NOUN
gra-1905	13	13	,	,	PUNCT
gra-1905	13	14	bronchial	bronchial	ADJ
gra-1905	13	15	asthma	asthma	NOUN
gra-1905	13	16	,	,	PUNCT
gra-1905	13	17	interstitial	interstitial	ADJ
gra-1905	13	18	lung	lung	NOUN
gra-1905	13	19	diseases	disease	NOUN
gra-1905	13	20	,	,	PUNCT
gra-1905	13	21	obstructive	obstructive	ADJ
gra-1905	13	22	sleep	sleep	NOUN
gra-1905	13	23	apnea	apnea	NOUN
gra-1905	13	24	and	and	CCONJ
gra-1905	13	25	lung	lung	NOUN
gra-1905	13	26	cancer	cancer	NOUN
gra-1905	13	27	.	.	PUNCT
gra-1905	14	1	ÿ	ÿ	DET
gra-1905	14	2	known	know	VERB
gra-1905	14	3	case	case	NOUN
gra-1905	14	4	of	of	ADP
gra-1905	14	5	ischemic	ischemic	ADJ
gra-1905	14	6	heart	heart	NOUN
gra-1905	14	7	disease	disease	NOUN
gra-1905	14	8	and	and	CCONJ
gra-1905	14	9	chronic	chronic	ADJ
gra-1905	14	10	renal	renal	ADJ
gra-1905	14	11	failure	failure	NOUN
gra-1905	14	12	.	.	PUNCT
gra-1905	15	1	ÿ	ÿ	DET
gra-1905	15	2	unstable	unstable	ADJ
gra-1905	15	3	copd	copd	NOUN
gra-1905	15	4	patients	patient	NOUN
gra-1905	15	5	with	with	ADP
gra-1905	15	6	acute	acute	ADJ
gra-1905	15	7	exacerbation	exacerbation	NOUN
gra-1905	15	8	.	.	PUNCT
gra-1905	16	1	patients	patient	NOUN
gra-1905	16	2	attending	attend	VERB
gra-1905	16	3	hospital	hospital	NOUN
gra-1905	16	4	with	with	ADP
gra-1905	16	5	cough	cough	NOUN
gra-1905	16	6	and	and	CCONJ
gra-1905	16	7	breathlessness	breathlessness	NOUN
gra-1905	16	8	were	be	AUX
gra-1905	16	9	evaluated	evaluate	VERB
gra-1905	16	10	for	for	ADP
gra-1905	16	11	copd	copd	NOUN
gra-1905	16	12	as	as	ADP
gra-1905	16	13	per	per	ADP
gra-1905	16	14	gold-2017	gold-2017	NOUN
gra-1905	16	15	.	.	PUNCT
gra-1905	17	1	all	all	DET
gra-1905	17	2	routine	routine	ADJ
gra-1905	17	3	blood	blood	NOUN
gra-1905	17	4	investigations	investigation	NOUN
gra-1905	17	5	including	include	VERB
gra-1905	17	6	complete	complete	ADJ
gra-1905	17	7	lipid	lipid	NOUN
gra-1905	17	8	prole	prole	PROPN
gra-1905	17	9	and	and	CCONJ
gra-1905	17	10	plasma	plasma	NOUN
gra-1905	17	11	glucose	glucose	NOUN
gra-1905	17	12	estimation	estimation	NOUN
gra-1905	17	13	(	(	PUNCT
gra-1905	17	14	fbs	fbs	PROPN
gra-1905	17	15	&	&	CCONJ
gra-1905	17	16	ogtt	ogtt	ADV
gra-1905	17	17	)	)	PUNCT
gra-1905	17	18	were	be	AUX
gra-1905	17	19	done	do	VERB
gra-1905	17	20	.	.	PUNCT
gra-1905	18	1	spirometry	spirometry	NOUN
gra-1905	18	2	with	with	ADP
gra-1905	18	3	reversibility	reversibility	NOUN
gra-1905	18	4	was	be	AUX
gra-1905	18	5	performed	perform	VERB
gra-1905	18	6	.	.	PUNCT
gra-1905	19	1	metabolic	metabolic	NOUN
gra-1905	19	2	syndrome	syndrome	NOUN
gra-1905	19	3	is	be	AUX
gra-1905	19	4	dened	dene	VERB
gra-1905	19	5	as	as	ADP
gra-1905	19	6	per	per	ADP
gra-1905	19	7	new	new	ADJ
gra-1905	19	8	international	international	ADJ
gra-1905	19	9	7diabetes	7diabetes	NUM
gra-1905	19	10	federation	federation	NOUN
gra-1905	19	11	idf	idf	PROPN
gra-1905	19	12	denition	denition	PROPN
gra-1905	19	13	(	(	PUNCT
gra-1905	19	14	idf	idf	PROPN
gra-1905	19	15	)	)	PUNCT
gra-1905	19	16	:	:	PUNCT
gra-1905	20	1	ÿ	ÿ	PROPN
gra-1905	20	2	central	central	ADJ
gra-1905	20	3	obesity	obesity	NOUN
gra-1905	20	4	(	(	PUNCT
gra-1905	20	5	dened	dene	VERB
gra-1905	20	6	as	as	ADP
gra-1905	20	7	waist	waist	NOUN
gra-1905	20	8	circumference	circumference	NOUN
gra-1905	20	9	>	>	PROPN
gra-1905	20	10	90	90	NUM
gra-1905	20	11	cm	cm	NOUN
gra-1905	20	12	for	for	ADP
gra-1905	20	13	men	man	NOUN
gra-1905	20	14	and	and	CCONJ
gra-1905	20	15	>	>	X
gra-1905	20	16	80	80	NUM
gra-1905	20	17	cm	cm	NOUN
gra-1905	20	18	for	for	ADP
gra-1905	20	19	women	woman	NOUN
gra-1905	20	20	,	,	PUNCT
gra-1905	20	21	with	with	ADP
gra-1905	20	22	ethnicity	ethnicity	NOUN
gra-1905	20	23	specic	specic	NOUN
gra-1905	20	24	values	value	NOUN
gra-1905	20	25	for	for	ADP
gra-1905	20	26	other	other	ADJ
gra-1905	20	27	groups	group	NOUN
gra-1905	20	28	)	)	PUNCT
gra-1905	20	29	ÿ	ÿ	PROPN
gra-1905	20	30	plus	plus	CCONJ
gra-1905	20	31	any	any	DET
gra-1905	20	32	two	two	NUM
gra-1905	20	33	of	of	ADP
gra-1905	20	34	the	the	DET
gra-1905	20	35	following	follow	VERB
gra-1905	20	36	four	four	NUM
gra-1905	20	37	factors	factor	NOUN
gra-1905	20	38	:	:	PUNCT
gra-1905	20	39	ÿ	ÿ	PROPN
gra-1905	20	40	raised	raise	VERB
gra-1905	20	41	tg	tg	ADP
gra-1905	20	42	level	level	NOUN
gra-1905	20	43	:	:	PUNCT
gra-1905	20	44	>	>	PUNCT
gra-1905	20	45	150	150	NUM
gra-1905	20	46	mg	mg	NUM
gra-1905	20	47	/	/	SYM
gra-1905	20	48	dl	dl	PROPN
gra-1905	20	49	(	(	PUNCT
gra-1905	20	50	1.7	1.7	NUM
gra-1905	20	51	mmol	mmol	NOUN
gra-1905	20	52	/	/	SYM
gra-1905	20	53	l	l	NOUN
gra-1905	20	54	)	)	PUNCT
gra-1905	20	55	,	,	PUNCT
gra-1905	20	56	or	or	CCONJ
gra-1905	20	57	specic	specic	VERB
gra-1905	20	58	treatment	treatment	NOUN
gra-1905	20	59	for	for	ADP
gra-1905	20	60	this	this	DET
gra-1905	20	61	lipid	lipid	NOUN
gra-1905	20	62	abnormality	abnormality	NOUN
gra-1905	20	63	.	.	PUNCT
gra-1905	21	1	ÿ	ÿ	PROPN
gra-1905	21	2	reduced	reduce	VERB
gra-1905	21	3	hdl	hdl	PROPN
gra-1905	21	4	cholesterol	cholesterol	PROPN
gra-1905	21	5	:	:	PUNCT
gra-1905	21	6	<	<	X
gra-1905	21	7	40	40	NUM
gra-1905	21	8	mg	mg	PROPN
gra-1905	21	9	/	/	SYM
gra-1905	21	10	dl	dl	PROPN
gra-1905	21	11	in	in	ADP
gra-1905	21	12	males	male	NOUN
gra-1905	21	13	and	and	CCONJ
gra-1905	21	14	<	<	X
gra-1905	21	15	50	50	NUM
gra-1905	21	16	mg	mg	PROPN
gra-1905	21	17	/	/	SYM
gra-1905	21	18	dl	dl	PROPN
gra-1905	21	19	in	in	ADP
gra-1905	21	20	females	female	NOUN
gra-1905	21	21	,	,	PUNCT
gra-1905	21	22	or	or	CCONJ
gra-1905	21	23	specic	specic	VERB
gra-1905	21	24	treatment	treatment	NOUN
gra-1905	21	25	for	for	ADP
gra-1905	21	26	this	this	DET
gra-1905	21	27	lipid	lipid	NOUN
gra-1905	21	28	abnormality	abnormality	NOUN
gra-1905	21	29	.	.	PUNCT
gra-1905	22	1	ÿ	ÿ	PROPN
gra-1905	22	2	raised	raise	VERB
gra-1905	22	3	blood	blood	NOUN
gra-1905	22	4	pressure	pressure	NOUN
gra-1905	22	5	:	:	PUNCT
gra-1905	22	6	systolic	systolic	ADJ
gra-1905	22	7	bp	bp	PROPN
gra-1905	22	8	≥130	≥130	NOUN
gra-1905	22	9	or	or	CCONJ
gra-1905	22	10	diastolic	diastolic	ADJ
gra-1905	22	11	bp	bp	PROPN
gra-1905	22	12	85	85	NUM
gra-1905	22	13	mm	mm	PROPN
gra-1905	22	14	hg	hg	NOUN
gra-1905	22	15	,	,	PUNCT
gra-1905	22	16	or	or	CCONJ
gra-1905	22	17	treatment	treatment	NOUN
gra-1905	22	18	of	of	ADP
gra-1905	22	19	previously	previously	ADV
gra-1905	22	20	diagnosed	diagnose	VERB
gra-1905	22	21	hypertension	hypertension	NOUN
gra-1905	22	22	.	.	PUNCT
gra-1905	23	1	ÿ	ÿ	PROPN
gra-1905	23	2	raised	raise	VERB
gra-1905	23	3	fasting	fast	VERB
gra-1905	23	4	plasma	plasma	NOUN
gra-1905	23	5	glucose	glucose	NOUN
gra-1905	23	6	(	(	PUNCT
gra-1905	23	7	fpg	fpg	NOUN
gra-1905	23	8	)	)	PUNCT
gra-1905	23	9	≥100	≥100	X
gra-1905	23	10	mg	mg	PROPN
gra-1905	23	11	/	/	SYM
gra-1905	23	12	dl	dl	PROPN
gra-1905	23	13	(	(	PUNCT
gra-1905	23	14	5.6	5.6	NUM
gra-1905	23	15	mmol	mmol	NOUN
gra-1905	23	16	/	/	SYM
gra-1905	23	17	l	l	NOUN
gra-1905	23	18	)	)	PUNCT
gra-1905	23	19	,	,	PUNCT
gra-1905	23	20	or	or	CCONJ
gra-1905	23	21	previously	previously	ADV
gra-1905	23	22	diagnosed	diagnose	VERB
gra-1905	23	23	type	type	NOUN
gra-1905	23	24	2	2	NUM
gra-1905	23	25	diabetes	diabetes	NOUN
gra-1905	23	26	.	.	PUNCT
gra-1905	24	1	ÿ	ÿ	PROPN
gra-1905	24	2	if	if	SCONJ
gra-1905	24	3	above	above	ADP
gra-1905	24	4	5.6	5.6	NUM
gra-1905	24	5	mmol	mmol	NOUN
gra-1905	24	6	/	/	SYM
gra-1905	24	7	l	l	NOUN
gra-1905	24	8	or	or	CCONJ
gra-1905	24	9	100	100	NUM
gra-1905	24	10	mg	mg	PROPN
gra-1905	24	11	/	/	SYM
gra-1905	24	12	dl	dl	PROPN
gra-1905	24	13	,	,	PUNCT
gra-1905	24	14	oral	oral	ADJ
gra-1905	24	15	glucose	glucose	NOUN
gra-1905	24	16	tolerance	tolerance	NOUN
gra-1905	24	17	test	test	NOUN
gra-1905	24	18	is	be	AUX
gra-1905	24	19	strongly	strongly	ADV
gra-1905	24	20	recommended	recommend	VERB
gra-1905	24	21	but	but	CCONJ
gra-1905	24	22	is	be	AUX
gra-1905	24	23	not	not	PART
gra-1905	24	24	necessary	necessary	ADJ
gra-1905	24	25	to	to	ADP
gra-1905	24	26	dene	dene	VERB
gra-1905	24	27	presence	presence	NOUN
gra-1905	24	28	of	of	ADP
gra-1905	24	29	the	the	DET
gra-1905	24	30	syndrome	syndrome	NOUN
gra-1905	24	31	.	.	PUNCT
gra-1905	25	1	statistical	statistical	ADJ
gra-1905	25	2	analysis	analysis	NOUN
gra-1905	25	3	statistical	statistical	ADJ
gra-1905	25	4	analyses	analysis	NOUN
gra-1905	25	5	were	be	AUX
gra-1905	25	6	performed	perform	VERB
gra-1905	25	7	using	use	VERB
gra-1905	25	8	spss	spss	PROPN
gra-1905	25	9	22.0	22.0	NUM
gra-1905	25	10	software	software	NOUN
gra-1905	25	11	package	package	NOUN
gra-1905	25	12	and	and	CCONJ
gra-1905	25	13	instat	instat	ADJ
gra-1905	25	14	graphpad	graphpad	NOUN
gra-1905	25	15	software	software	NOUN
gra-1905	25	16	.	.	PUNCT
gra-1905	26	1	variables	variable	NOUN
gra-1905	26	2	were	be	AUX
gra-1905	26	3	analyzed	analyze	VERB
gra-1905	26	4	using	use	VERB
gra-1905	26	5	student	student	NOUN
gra-1905	26	6	's	's	PART
gra-1905	26	7	t	t	NOUN
gra-1905	26	8	test	test	NOUN
gra-1905	26	9	and	and	CCONJ
gra-1905	26	10	p	p	NOUN
gra-1905	26	11	value	value	NOUN
gra-1905	26	12	less	less	ADJ
gra-1905	26	13	than	than	ADP
gra-1905	26	14	0.05	0.05	NUM
gra-1905	26	15	was	be	AUX
gra-1905	26	16	considered	consider	VERB
gra-1905	26	17	signicant	signicant	ADJ
gra-1905	26	18	.	.	PUNCT
gra-1905	27	1	results	result	NOUN
gra-1905	27	2	total	total	VERB
gra-1905	27	3	67	67	NUM
gra-1905	27	4	patients	patient	NOUN
gra-1905	27	5	were	be	AUX
gra-1905	27	6	included	include	VERB
gra-1905	27	7	for	for	ADP
gra-1905	27	8	nal	nal	ADJ
gra-1905	27	9	analysis	analysis	NOUN
gra-1905	27	10	after	after	ADP
gra-1905	27	11	exclu	exclu	PROPN
gra-1905	27	12	sion	sion	PROPN
gra-1905	27	13	criteria	criterion	NOUN
gra-1905	27	14	.	.	PUNCT
gra-1905	28	1	mean	mean	VERB
gra-1905	28	2	age	age	NOUN
gra-1905	28	3	of	of	ADP
gra-1905	28	4	male	male	NOUN
gra-1905	28	5	was	be	AUX
gra-1905	28	6	58.67	58.67	NUM
gra-1905	28	7	±	±	NUM
gra-1905	28	8	9.87	9.87	NUM
gra-1905	28	9	years	year	NOUN
gra-1905	28	10	while	while	SCONJ
gra-1905	28	11	mean	mean	VERB
gra-1905	28	12	age	age	NOUN
gra-1905	28	13	of	of	ADP
gra-1905	28	14	female	female	NOUN
gra-1905	28	15	was	be	AUX
gra-1905	28	16	57.23	57.23	NUM
gra-1905	28	17	±	±	NUM
gra-1905	28	18	10.40	10.40	NUM
gra-1905	28	19	years	year	NOUN
gra-1905	28	20	.	.	PUNCT
gra-1905	29	1	overall	overall	ADJ
gra-1905	29	2	percentage	percentage	NOUN
gra-1905	29	3	of	of	ADP
gra-1905	29	4	obese	obese	ADJ
gra-1905	29	5	,	,	PUNCT
gra-1905	29	6	overweight	overweight	ADJ
gra-1905	29	7	,	,	PUNCT
gra-1905	29	8	normal	normal	ADJ
gra-1905	29	9	weight	weight	NOUN
gra-1905	29	10	and	and	CCONJ
gra-1905	29	11	underweight	underweight	NOUN
gra-1905	29	12	were	be	AUX
gra-1905	29	13	31.3	31.3	NUM
gra-1905	29	14	%	%	NOUN
gra-1905	29	15	,	,	PUNCT
gra-1905	29	16	23.9	23.9	NUM
gra-1905	29	17	%	%	NOUN
gra-1905	29	18	,	,	PUNCT
gra-1905	29	19	29.8	29.8	NUM
gra-1905	29	20	%	%	NOUN
gra-1905	29	21	and	and	CCONJ
gra-1905	29	22	14.9	14.9	NUM
gra-1905	29	23	%	%	NOUN
gra-1905	29	24	respectively	respectively	ADV
gra-1905	29	25	.	.	PUNCT
gra-1905	30	1	50	50	NUM
gra-1905	30	2	%	%	NOUN
gra-1905	30	3	female	female	ADJ
gra-1905	30	4	and	and	CCONJ
gra-1905	30	5	22.2	22.2	NUM
gra-1905	30	6	%	%	NOUN
gra-1905	30	7	male	male	NOUN
gra-1905	30	8	were	be	AUX
gra-1905	30	9	obese	obese	ADJ
gra-1905	30	10	.	.	PUNCT
gra-1905	31	1	mean	mean	VERB
gra-1905	31	2	2bmi	2bmi	NUM
gra-1905	31	3	of	of	ADP
gra-1905	31	4	male	male	NOUN
gra-1905	31	5	was	be	AUX
gra-1905	31	6	24.33±6.64	24.33±6.64	NUM
gra-1905	31	7	kg	kg	NOUN
gra-1905	31	8	/	/	SYM
gra-1905	31	9	m	m	PROPN
gra-1905	31	10	and	and	CCONJ
gra-1905	31	11	mean	mean	VERB
gra-1905	31	12	bmi	bmi	NOUN
gra-1905	31	13	of	of	ADP
gra-1905	31	14	study	study	NOUN
gra-1905	31	15	2population	2population	PROPN
gra-1905	31	16	was	be	AUX
gra-1905	31	17	26.22±7.22	26.22±7.22	NUM
gra-1905	31	18	kg	kg	NOUN
gra-1905	31	19	/	/	SYM
gra-1905	31	20	m	m	PROPN
gra-1905	31	21	.	.	PUNCT
gra-1905	32	1	the	the	DET
gra-1905	32	2	mean	mean	ADJ
gra-1905	32	3	waist	waist	NOUN
gra-1905	32	4	circumference	circumference	NOUN
gra-1905	32	5	of	of	ADP
gra-1905	32	6	male	male	NOUN
gra-1905	32	7	was	be	AUX
gra-1905	32	8	86.91±13.31	86.91±13.31	NUM
gra-1905	32	9	cm	cm	NOUN
gra-1905	32	10	while	while	SCONJ
gra-1905	32	11	in	in	ADP
gra-1905	32	12	female	female	ADJ
gra-1905	32	13	it	it	PRON
gra-1905	32	14	was	be	AUX
gra-1905	32	15	87.18±14.51	87.18±14.51	NOUN
gra-1905	32	16	cm	cm	NOUN
gra-1905	32	17	.	.	PUNCT
gra-1905	33	1	most	most	ADJ
gra-1905	33	2	parameters	parameter	NOUN
gra-1905	33	3	of	of	ADP
gra-1905	33	4	lipid	lipid	PROPN
gra-1905	33	5	prole	prole	PROPN
gra-1905	33	6	were	be	AUX
gra-1905	33	7	deranged	derange	VERB
gra-1905	33	8	in	in	ADP
gra-1905	33	9	study	study	NOUN
gra-1905	33	10	population	population	NOUN
gra-1905	33	11	.	.	PUNCT
gra-1905	34	1	among	among	ADP
gra-1905	34	2	all	all	DET
gra-1905	34	3	parameters	parameter	NOUN
gra-1905	34	4	of	of	ADP
gra-1905	34	5	lipid	lipid	NOUN
gra-1905	34	6	prole	prole	PROPN
gra-1905	34	7	,	,	PUNCT
gra-1905	34	8	raised	raise	VERB
gra-1905	34	9	triglyceride	triglyceride	ADV
gra-1905	34	10	was	be	AUX
gra-1905	34	11	found	find	VERB
gra-1905	34	12	in	in	ADP
gra-1905	34	13	majority	majority	NOUN
gra-1905	34	14	of	of	ADP
gra-1905	34	15	patients	patient	NOUN
gra-1905	34	16	(	(	PUNCT
gra-1905	34	17	69.4	69.4	NUM
gra-1905	34	18	%	%	NOUN
gra-1905	34	19	)	)	PUNCT
gra-1905	34	20	followed	follow	VERB
gra-1905	34	21	a	a	DET
gra-1905	34	22	study	study	NOUN
gra-1905	34	23	to	to	PART
gra-1905	34	24	investigate	investigate	VERB
gra-1905	34	25	the	the	DET
gra-1905	34	26	prevalence	prevalence	NOUN
gra-1905	34	27	of	of	ADP
gra-1905	34	28	metabolic	metabolic	NOUN
gra-1905	34	29	syndrome	syndrome	NOUN
gra-1905	34	30	in	in	ADP
gra-1905	34	31	stable	stable	ADJ
gra-1905	34	32	chronic	chronic	ADJ
gra-1905	34	33	obstructive	obstructive	ADJ
gra-1905	34	34	pulmonary	pulmonary	ADJ
gra-1905	34	35	disease	disease	NOUN
gra-1905	34	36	patients	patient	VERB
gra-1905	34	37	original	original	ADJ
gra-1905	34	38	research	research	NOUN
gra-1905	34	39	paper	paper	NOUN
gra-1905	34	40	dr	dr	PROPN
gra-1905	34	41	sachin	sachin	PROPN
gra-1905	34	42	kumar	kumar	PROPN
gra-1905	34	43	gupta	gupta	PROPN
gra-1905	34	44	(	(	PUNCT
gra-1905	34	45	senior	senior	ADJ
gra-1905	34	46	resident	resident	NOUN
gra-1905	34	47	)	)	PUNCT
gra-1905	34	48	dept	dept	NOUN
gra-1905	34	49	of	of	ADP
gra-1905	34	50	respiratory	respiratory	ADJ
gra-1905	34	51	medicine	medicine	NOUN
gra-1905	34	52	,	,	PUNCT
gra-1905	34	53	ird	ird	PROPN
gra-1905	34	54	,	,	PUNCT
gra-1905	34	55	sms	sms	PROPN
gra-1905	34	56	medical	medical	PROPN
gra-1905	34	57	college	college	PROPN
gra-1905	34	58	,	,	PUNCT
gra-1905	34	59	jaipur	jaipur	PROPN
gra-1905	34	60	x	x	SYM
gra-1905	34	61	3gjra	3gjra	NUM
gra-1905	34	62	global	global	ADJ
gra-1905	34	63	journal	journal	NOUN
gra-1905	34	64	for	for	ADP
gra-1905	34	65	research	research	NOUN
gra-1905	34	66	analysis	analysis	NOUN
gra-1905	34	67	respiratory	respiratory	ADJ
gra-1905	34	68	medicine	medicine	NOUN
gra-1905	34	69	background	background	NOUN
gra-1905	34	70	:	:	PUNCT
gra-1905	34	71	chronic	chronic	ADJ
gra-1905	34	72	obstructive	obstructive	ADJ
gra-1905	34	73	pulmonary	pulmonary	ADJ
gra-1905	34	74	disease	disease	NOUN
gra-1905	34	75	(	(	PUNCT
gra-1905	34	76	copd	copd	PROPN
gra-1905	34	77	)	)	PUNCT
gra-1905	34	78	is	be	AUX
gra-1905	34	79	associated	associate	VERB
gra-1905	34	80	with	with	ADP
gra-1905	34	81	several	several	ADJ
gra-1905	34	82	extrapulmonary	extrapulmonary	ADJ
gra-1905	34	83	systemic	systemic	ADJ
gra-1905	34	84	manifestations	manifestation	NOUN
gra-1905	34	85	including	include	VERB
gra-1905	34	86	metabolic	metabolic	NOUN
gra-1905	34	87	syndrome	syndrome	NOUN
gra-1905	34	88	.	.	PUNCT
gra-1905	35	1	metabolic	metabolic	NOUN
gra-1905	35	2	syndrome	syndrome	NOUN
gra-1905	35	3	is	be	AUX
gra-1905	35	4	an	an	DET
gra-1905	35	5	aggregate	aggregate	NOUN
gra-1905	35	6	of	of	ADP
gra-1905	35	7	inter	inter	ADJ
gra-1905	35	8	-	-	ADJ
gra-1905	35	9	related	relate	VERB
gra-1905	35	10	cardio	cardio	NOUN
gra-1905	35	11	-	-	PUNCT
gra-1905	35	12	metabolic	metabolic	NOUN
gra-1905	35	13	risk	risk	NOUN
gra-1905	35	14	factors	factor	NOUN
gra-1905	35	15	,	,	PUNCT
gra-1905	35	16	comprising	comprise	VERB
gra-1905	35	17	glucose	glucose	NOUN
gra-1905	35	18	intolerance	intolerance	NOUN
gra-1905	35	19	,	,	PUNCT
gra-1905	35	20	abdominal	abdominal	ADJ
gra-1905	35	21	obesity	obesity	NOUN
gra-1905	35	22	,	,	PUNCT
gra-1905	35	23	dyslipidemia	dyslipidemia	NOUN
gra-1905	35	24	and	and	CCONJ
gra-1905	35	25	hypertension	hypertension	NOUN
gra-1905	35	26	,	,	PUNCT
gra-1905	35	27	which	which	PRON
gra-1905	35	28	are	be	AUX
gra-1905	35	29	associated	associate	VERB
gra-1905	35	30	with	with	ADP
gra-1905	35	31	an	an	DET
gra-1905	35	32	increased	increase	VERB
gra-1905	35	33	risk	risk	NOUN
gra-1905	35	34	of	of	ADP
gra-1905	35	35	cardiovascular	cardiovascular	ADJ
gra-1905	35	36	disease	disease	NOUN
gra-1905	35	37	and	and	CCONJ
gra-1905	35	38	type-2	type-2	NUM
gra-1905	35	39	diabetes	diabetes	NOUN
gra-1905	35	40	.	.	PUNCT
gra-1905	36	1	the	the	DET
gra-1905	36	2	objective	objective	NOUN
gra-1905	36	3	of	of	ADP
gra-1905	36	4	study	study	NOUN
gra-1905	36	5	was	be	AUX
gra-1905	36	6	to	to	PART
gra-1905	36	7	assess	assess	VERB
gra-1905	36	8	prevalence	prevalence	NOUN
gra-1905	36	9	of	of	ADP
gra-1905	36	10	metabolic	metabolic	NOUN
gra-1905	36	11	syndrome	syndrome	NOUN
gra-1905	36	12	among	among	ADP
gra-1905	36	13	copd	copd	NOUN
gra-1905	36	14	patients	patient	NOUN
gra-1905	36	15	.	.	PUNCT
gra-1905	37	1	methods	method	NOUN
gra-1905	37	2	:	:	PUNCT
gra-1905	37	3	this	this	DET
gra-1905	37	4	cross	cross	ADJ
gra-1905	37	5	-	-	ADJ
gra-1905	37	6	sectional	sectional	ADJ
gra-1905	37	7	study	study	NOUN
gra-1905	37	8	was	be	AUX
gra-1905	37	9	conducted	conduct	VERB
gra-1905	37	10	from	from	ADP
gra-1905	37	11	april	april	PROPN
gra-1905	37	12	2017	2017	NUM
gra-1905	37	13	to	to	ADP
gra-1905	37	14	march	march	PROPN
gra-1905	37	15	2018	2018	NUM
gra-1905	37	16	.	.	PUNCT
gra-1905	38	1	total	total	NOUN
gra-1905	38	2	67	67	NUM
gra-1905	38	3	copd	copd	NOUN
gra-1905	38	4	patients	patient	NOUN
gra-1905	38	5	were	be	AUX
gra-1905	38	6	classied	classied	PROPN
gra-1905	38	7	according	accord	VERB
gra-1905	38	8	to	to	ADP
gra-1905	38	9	gold	gold	NOUN
gra-1905	38	10	guideline	guideline	NOUN
gra-1905	38	11	.	.	PUNCT
gra-1905	39	1	international	international	ADJ
gra-1905	39	2	diabetes	diabetes	PROPN
gra-1905	39	3	federation	federation	PROPN
gra-1905	39	4	(	(	PUNCT
gra-1905	39	5	idf	idf	PROPN
gra-1905	39	6	)	)	PUNCT
gra-1905	39	7	guideline	guideline	NOUN
gra-1905	39	8	was	be	AUX
gra-1905	39	9	used	use	VERB
gra-1905	39	10	for	for	ADP
gra-1905	39	11	metabolic	metabolic	ADJ
gra-1905	39	12	syndrome(mets	syndrome(met	NOUN
gra-1905	39	13	)	)	PUNCT
gra-1905	39	14	.	.	PUNCT
gra-1905	40	1	results	result	NOUN
gra-1905	40	2	:	:	PUNCT
gra-1905	40	3	prevalence	prevalence	NOUN
gra-1905	40	4	of	of	ADP
gra-1905	40	5	mets	met	NOUN
gra-1905	40	6	was	be	AUX
gra-1905	40	7	29.85	29.85	NUM
gra-1905	40	8	%	%	NOUN
gra-1905	40	9	,	,	PUNCT
gra-1905	40	10	highest	high	ADJ
gra-1905	40	11	(	(	PUNCT
gra-1905	40	12	47.06	47.06	NUM
gra-1905	40	13	%	%	NOUN
gra-1905	40	14	)	)	PUNCT
gra-1905	40	15	in	in	ADP
gra-1905	40	16	gold	gold	NOUN
gra-1905	40	17	stage	stage	NOUN
gra-1905	40	18	-	-	PUNCT
gra-1905	40	19	ii	ii	NOUN
gra-1905	40	20	,	,	PUNCT
gra-1905	40	21	followed	follow	VERB
gra-1905	40	22	by	by	ADP
gra-1905	40	23	stage	stage	NOUN
gra-1905	40	24	-	-	PUNCT
gra-1905	40	25	i	i	PRON
gra-1905	40	26	(	(	PUNCT
gra-1905	40	27	40	40	NUM
gra-1905	40	28	%	%	NOUN
gra-1905	40	29	)	)	PUNCT
gra-1905	40	30	.	.	PUNCT
gra-1905	41	1	conclusions	conclusion	NOUN
gra-1905	41	2	:	:	PUNCT
gra-1905	41	3	the	the	DET
gra-1905	41	4	presence	presence	NOUN
gra-1905	41	5	of	of	ADP
gra-1905	41	6	metabolic	metabolic	NOUN
gra-1905	41	7	syndrome	syndrome	NOUN
gra-1905	41	8	is	be	AUX
gra-1905	41	9	common	common	ADJ
gra-1905	41	10	in	in	ADP
gra-1905	41	11	patients	patient	NOUN
gra-1905	41	12	with	with	ADP
gra-1905	41	13	copd	copd	PROPN
gra-1905	41	14	and	and	CCONJ
gra-1905	41	15	all	all	DET
gra-1905	41	16	copd	copd	NOUN
gra-1905	41	17	patients	patient	NOUN
gra-1905	41	18	should	should	AUX
gra-1905	41	19	be	be	AUX
gra-1905	41	20	considered	consider	VERB
gra-1905	41	21	for	for	ADP
gra-1905	41	22	its	its	PRON
gra-1905	41	23	screening	screening	NOUN
gra-1905	41	24	.	.	PUNCT
gra-1905	42	1	abstract	abstract	ADJ
gra-1905	42	2	keywords	keyword	NOUN
gra-1905	42	3	:	:	PUNCT
gra-1905	42	4	chronic	chronic	ADJ
gra-1905	42	5	obstructive	obstructive	ADJ
gra-1905	42	6	pulmonary	pulmonary	ADJ
gra-1905	42	7	disease	disease	NOUN
gra-1905	42	8	,	,	PUNCT
gra-1905	42	9	metabolic	metabolic	NOUN
gra-1905	42	10	syndrome	syndrome	NOUN
gra-1905	42	11	volume-9	volume-9	PROPN
gra-1905	42	12	,	,	PUNCT
gra-1905	42	13	issue-2	issue-2	PROPN
gra-1905	42	14	,	,	PUNCT
gra-1905	42	15	february-2020	february-2020	VERB
gra-1905	42	16	•	•	NUM
gra-1905	42	17	print	print	NOUN
gra-1905	42	18	issn	issn	PROPN
gra-1905	42	19	no	no	NOUN
gra-1905	42	20	.	.	PROPN
gra-1905	42	21	2277	2277	NUM
gra-1905	42	22	8160	8160	NUM
gra-1905	42	23	•	•	NOUN
gra-1905	42	24	doi	doi	NOUN
gra-1905	42	25	:	:	PUNCT
gra-1905	42	26	10.36106	10.36106	NUM
gra-1905	42	27	/	/	SYM
gra-1905	42	28	gjra	gjra	PROPN
gra-1905	42	29	dr	dr	PROPN
gra-1905	42	30	aashish	aashish	PROPN
gra-1905	42	31	kumar	kumar	PROPN
gra-1905	42	32	singh	singh	PROPN
gra-1905	42	33	*	*	PUNCT
gra-1905	42	34	(	(	PUNCT
gra-1905	42	35	assoc	assoc	PROPN
gra-1905	42	36	prof	prof	PROPN
gra-1905	42	37	)	)	PUNCT
gra-1905	42	38	dept	dept	NOUN
gra-1905	42	39	of	of	ADP
gra-1905	42	40	respiratory	respiratory	ADJ
gra-1905	42	41	medicine	medicine	NOUN
gra-1905	42	42	,	,	PUNCT
gra-1905	42	43	ird	ird	PROPN
gra-1905	42	44	,	,	PUNCT
gra-1905	42	45	sms	sms	PROPN
gra-1905	42	46	medical	medical	PROPN
gra-1905	42	47	college	college	PROPN
gra-1905	42	48	,	,	PUNCT
gra-1905	42	49	jaipur	jaipur	NOUN
gra-1905	42	50	*	*	PUNCT
gra-1905	42	51	corresponding	correspond	VERB
gra-1905	42	52	author	author	NOUN
gra-1905	42	53	4	4	NUM
gra-1905	42	54	x	x	NOUN
gra-1905	42	55	gjra	gjra	ADJ
gra-1905	42	56	global	global	ADJ
gra-1905	42	57	journal	journal	PROPN
gra-1905	42	58	for	for	ADP
gra-1905	42	59	research	research	NOUN
gra-1905	42	60	analysis	analysis	NOUN
gra-1905	42	61	prevalence	prevalence	NOUN
gra-1905	42	62	of	of	ADP
gra-1905	42	63	metabolic	metabolic	NOUN
gra-1905	42	64	syndrome	syndrome	NOUN
gra-1905	42	65	in	in	ADP
gra-1905	42	66	our	our	PRON
gra-1905	42	67	study	study	NOUN
gra-1905	42	68	was	be	AUX
gra-1905	42	69	29.85	29.85	NUM
gra-1905	42	70	%	%	NOUN
gra-1905	42	71	.	.	PUNCT
gra-1905	43	1	metabolic	metabolic	NOUN
gra-1905	43	2	syndrome	syndrome	NOUN
gra-1905	43	3	was	be	AUX
gra-1905	43	4	most	most	ADV
gra-1905	43	5	common	common	ADJ
gra-1905	43	6	in	in	ADP
gra-1905	43	7	gold	gold	NOUN
gra-1905	43	8	stage	stage	NOUN
gra-1905	43	9	-	-	PUNCT
gra-1905	43	10	ii	ii	NOUN
gra-1905	43	11	(	(	PUNCT
gra-1905	43	12	47.06	47.06	NUM
gra-1905	43	13	%	%	NOUN
gra-1905	43	14	)	)	PUNCT
gra-1905	43	15	.	.	PUNCT
gra-1905	44	1	(	(	PUNCT
gra-1905	44	2	table-2	table-2	NUM
gra-1905	44	3	)	)	PUNCT
gra-1905	44	4	table-2	table-2	NUM
gra-1905	44	5	discussion	discussion	NOUN
gra-1905	44	6	prevalence	prevalence	NOUN
gra-1905	44	7	of	of	ADP
gra-1905	44	8	metabolic	metabolic	NOUN
gra-1905	44	9	syndrome	syndrome	NOUN
gra-1905	44	10	in	in	ADP
gra-1905	44	11	our	our	PRON
gra-1905	44	12	study	study	NOUN
gra-1905	44	13	was	be	AUX
gra-1905	44	14	29.85	29.85	NUM
gra-1905	44	15	%	%	NOUN
gra-1905	44	16	(	(	PUNCT
gra-1905	44	17	40.91%in	40.91%in	NOUN
gra-1905	44	18	female	female	ADJ
gra-1905	44	19	and	and	CCONJ
gra-1905	44	20	24.44	24.44	NUM
gra-1905	44	21	%	%	NOUN
gra-1905	44	22	in	in	ADP
gra-1905	44	23	male	male	NOUN
gra-1905	44	24	)	)	PUNCT
gra-1905	44	25	.	.	PUNCT
gra-1905	45	1	metabolic	metabolic	NOUN
gra-1905	45	2	syndrome	syndrome	PROPN
gra-1905	45	3	was	be	AUX
gra-1905	45	4	most	most	ADV
gra-1905	45	5	common	common	ADJ
gra-1905	45	6	in	in	ADP
gra-1905	45	7	gold	gold	NOUN
gra-1905	45	8	stage	stage	NOUN
gra-1905	45	9	-	-	PUNCT
gra-1905	45	10	ii	ii	NOUN
gra-1905	45	11	(	(	PUNCT
gra-1905	45	12	47.06	47.06	NUM
gra-1905	45	13	%	%	NOUN
gra-1905	45	14	)	)	PUNCT
gra-1905	45	15	followed	follow	VERB
gra-1905	45	16	by	by	ADP
gra-1905	45	17	stage	stage	NOUN
gra-1905	45	18	-	-	PUNCT
gra-1905	45	19	i	i	PRON
gra-1905	45	20	(	(	PUNCT
gra-1905	45	21	40	40	NUM
gra-1905	45	22	%	%	NOUN
gra-1905	45	23	)	)	PUNCT
gra-1905	45	24	followed	follow	VERB
gra-1905	45	25	by	by	ADP
gra-1905	45	26	stage	stage	NOUN
gra-1905	45	27	-	-	PUNCT
gra-1905	45	28	iii	iii	NOUN
gra-1905	45	29	(	(	PUNCT
gra-1905	45	30	25.71	25.71	NUM
gra-1905	45	31	%	%	NOUN
gra-1905	45	32	)	)	PUNCT
gra-1905	45	33	and	and	CCONJ
gra-1905	45	34	it	it	PRON
gra-1905	45	35	was	be	AUX
gra-1905	45	36	only	only	ADV
gra-1905	45	37	810	810	NUM
gra-1905	45	38	%	%	NOUN
gra-1905	45	39	in	in	ADP
gra-1905	45	40	stageiv	stageiv	NOUN
gra-1905	45	41	.	.	PUNCT
gra-1905	46	1	henrik	henrik	PROPN
gra-1905	46	2	watz	watz	PROPN
gra-1905	46	3	et	et	PROPN
gra-1905	46	4	al	al	PROPN
gra-1905	46	5	reported	report	VERB
gra-1905	46	6	metabolic	metabolic	NOUN
gra-1905	46	7	syndrome	syndrome	NOUN
gra-1905	46	8	in	in	ADP
gra-1905	46	9	47.5	47.5	NUM
gra-1905	46	10	%	%	NOUN
gra-1905	46	11	patients	patient	NOUN
gra-1905	46	12	with	with	ADP
gra-1905	46	13	highest	high	ADJ
gra-1905	46	14	(	(	PUNCT
gra-1905	46	15	53	53	NUM
gra-1905	46	16	%	%	NOUN
gra-1905	46	17	)	)	PUNCT
gra-1905	46	18	in	in	ADP
gra-1905	46	19	stageii	stageii	PROPN
gra-1905	46	20	,	,	PUNCT
gra-1905	46	21	50	50	NUM
gra-1905	46	22	%	%	NOUN
gra-1905	46	23	in	in	ADP
gra-1905	46	24	stage	stage	NOUN
gra-1905	46	25	-	-	PUNCT
gra-1905	46	26	i	i	PRON
gra-1905	46	27	,	,	PUNCT
gra-1905	46	28	44	44	NUM
gra-1905	46	29	%	%	NOUN
gra-1905	46	30	in	in	ADP
gra-1905	46	31	stage	stage	NOUN
gra-1905	46	32	-	-	PUNCT
gra-1905	46	33	iv	iv	NUM
gra-1905	46	34	and	and	CCONJ
gra-1905	46	35	37	37	NUM
gra-1905	46	36	%	%	NOUN
gra-1905	46	37	in	in	ADP
gra-1905	46	38	stage	stage	NOUN
gra-1905	46	39	-	-	PUNCT
gra-1905	46	40	iii	iii	NOUN
gra-1905	46	41	.	.	PUNCT
gra-1905	46	42	jesús	jesús	PROPN
gra-1905	46	43	9díez	9díez	PROPN
gra-1905	46	44	-	-	SYM
gra-1905	46	45	manglano	manglano	PROPN
gra-1905	46	46	et	et	PROPN
gra-1905	46	47	al	al	PROPN
gra-1905	46	48	found	find	VERB
gra-1905	46	49	the	the	DET
gra-1905	46	50	overall	overall	ADJ
gra-1905	46	51	prevalence	prevalence	NOUN
gra-1905	46	52	of	of	ADP
gra-1905	46	53	metabolic	metabolic	NOUN
gra-1905	46	54	syndrome	syndrome	NOUN
gra-1905	46	55	in	in	ADP
gra-1905	46	56	copd	copd	PROPN
gra-1905	46	57	patients	patient	NOUN
gra-1905	46	58	was	be	AUX
gra-1905	46	59	42.9	42.9	NUM
gra-1905	46	60	%	%	NOUN
gra-1905	46	61	,	,	PUNCT
gra-1905	46	62	being	be	AUX
gra-1905	46	63	more	more	ADV
gra-1905	46	64	10frequent	10frequent	ADJ
gra-1905	46	65	in	in	ADP
gra-1905	46	66	female	female	ADJ
gra-1905	46	67	(	(	PUNCT
gra-1905	46	68	59.5	59.5	NUM
gra-1905	46	69	%	%	NOUN
gra-1905	46	70	)	)	PUNCT
gra-1905	46	71	.	.	PUNCT
gra-1905	47	1	marquis	marquis	PROPN
gra-1905	47	2	et	et	PROPN
gra-1905	47	3	al	al	PROPN
gra-1905	47	4	found	find	VERB
gra-1905	47	5	frequency	frequency	NOUN
gra-1905	47	6	of	of	ADP
gra-1905	47	7	metabolic	metabolic	NOUN
gra-1905	47	8	syndrome	syndrome	NOUN
gra-1905	47	9	in	in	ADP
gra-1905	47	10	patients	patient	NOUN
gra-1905	47	11	with	with	ADP
gra-1905	47	12	copd	copd	PROPN
gra-1905	47	13	was	be	AUX
gra-1905	47	14	21	21	NUM
gra-1905	47	15	%	%	NOUN
gra-1905	47	16	and	and	CCONJ
gra-1905	47	17	the	the	DET
gra-1905	47	18	frequency	frequency	NOUN
gra-1905	47	19	decreases	decrease	VERB
gra-1905	47	20	to	to	ADP
gra-1905	47	21	about	about	ADV
gra-1905	47	22	10	10	NUM
gra-1905	47	23	%	%	NOUN
gra-1905	47	24	at	at	ADP
gra-1905	47	25	gold	gold	NOUN
gra-1905	47	26	stages	stage	NOUN
gra-1905	47	27	iii	iii	NOUN
gra-1905	47	28	and	and	CCONJ
gra-1905	47	29	iv	iv	X
gra-1905	47	30	.	.	PUNCT
gra-1905	48	1	there	there	PRON
gra-1905	48	2	was	be	VERB
gra-1905	48	3	no	no	DET
gra-1905	48	4	evidence	evidence	NOUN
gra-1905	48	5	that	that	SCONJ
gra-1905	48	6	the	the	DET
gra-1905	48	7	relation	relation	NOUN
gra-1905	48	8	between	between	ADP
gra-1905	48	9	airow	airow	NUM
gra-1905	48	10	obstruction	obstruction	NOUN
gra-1905	48	11	and	and	CCONJ
gra-1905	48	12	metabolic	metabolic	NOUN
gra-1905	48	13	syndrome	syndrome	NOUN
gra-1905	48	14	varied	varied	ADJ
gra-1905	48	15	with	with	ADP
gra-1905	48	16	smoking	smoking	NOUN
gra-1905	48	17	.	.	PUNCT
gra-1905	49	1	maximum	maximum	ADJ
gra-1905	49	2	patients	patient	NOUN
gra-1905	49	3	of	of	ADP
gra-1905	49	4	metabolic	metabolic	NOUN
gra-1905	49	5	syndrome	syndrome	NOUN
gra-1905	49	6	(	(	PUNCT
gra-1905	49	7	45.5	45.5	NUM
gra-1905	49	8	%	%	NOUN
gra-1905	49	9	)	)	PUNCT
gra-1905	49	10	were	be	AUX
gra-1905	49	11	in	in	ADP
gra-1905	49	12	stage	stage	NOUN
gra-1905	49	13	-	-	PUNCT
gra-1905	49	14	i	i	PROPN
gra-1905	49	15	&	&	CCONJ
gra-1905	49	16	ii	ii	PROPN
gra-1905	49	17	combined	combine	VERB
gra-1905	49	18	and	and	CCONJ
gra-1905	49	19	only	only	ADV
gra-1905	49	20	22.2	22.2	NUM
gra-1905	49	21	%	%	NOUN
gra-1905	49	22	of	of	ADP
gra-1905	49	23	patients	patient	NOUN
gra-1905	49	24	were	be	AUX
gra-1905	49	25	in	in	ADP
gra-1905	49	26	stageiii	stageiii	NOUN
gra-1905	49	27	&	&	CCONJ
gra-1905	49	28	iv	iv	NUM
gra-1905	49	29	combined	combine	VERB
gra-1905	49	30	in	in	ADP
gra-1905	49	31	our	our	PRON
gra-1905	49	32	study	study	NOUN
gra-1905	49	33	.	.	PUNCT
gra-1905	50	1	however	however	ADV
gra-1905	50	2	,	,	PUNCT
gra-1905	50	3	no	no	DET
gra-1905	50	4	signicant	signicant	ADJ
gra-1905	50	5	variation	variation	NOUN
gra-1905	50	6	was	be	AUX
gra-1905	50	7	found	find	VERB
gra-1905	50	8	in	in	ADP
gra-1905	50	9	triglyceride	triglyceride	ADJ
gra-1905	50	10	levels	level	NOUN
gra-1905	50	11	,	,	PUNCT
gra-1905	50	12	hdl	hdl	PROPN
gra-1905	50	13	levels	level	NOUN
gra-1905	50	14	,	,	PUNCT
gra-1905	50	15	raised	raise	VERB
gra-1905	50	16	bp	bp	PROPN
gra-1905	50	17	and	and	CCONJ
gra-1905	50	18	raised	raise	VERB
gra-1905	50	19	fbs	fbs	PROPN
gra-1905	50	20	among	among	ADP
gra-1905	50	21	various	various	ADJ
gra-1905	50	22	stages	stage	NOUN
gra-1905	50	23	of	of	ADP
gra-1905	50	24	copd	copd	NOUN
gra-1905	50	25	.	.	PUNCT
gra-1905	51	1	it	it	PRON
gra-1905	51	2	means	mean	VERB
gra-1905	51	3	that	that	SCONJ
gra-1905	51	4	all	all	DET
gra-1905	51	5	parameters	parameter	NOUN
gra-1905	51	6	except	except	SCONJ
gra-1905	51	7	central	central	ADJ
gra-1905	51	8	obesity	obesity	NOUN
gra-1905	51	9	were	be	AUX
gra-1905	51	10	present	present	ADJ
gra-1905	51	11	in	in	ADP
gra-1905	51	12	population	population	NOUN
gra-1905	51	13	and	and	CCONJ
gra-1905	51	14	they	they	PRON
gra-1905	51	15	were	be	AUX
gra-1905	51	16	not	not	PART
gra-1905	51	17	affected	affect	VERB
gra-1905	51	18	by	by	ADP
gra-1905	51	19	different	different	ADJ
gra-1905	51	20	gold	gold	NOUN
gra-1905	51	21	stages	stage	NOUN
gra-1905	51	22	.	.	PUNCT
gra-1905	52	1	2mean	2mean	NUM
gra-1905	52	2	bmi	bmi	NOUN
gra-1905	52	3	of	of	ADP
gra-1905	52	4	males	male	NOUN
gra-1905	52	5	in	in	ADP
gra-1905	52	6	our	our	PRON
gra-1905	52	7	study	study	NOUN
gra-1905	52	8	was	be	AUX
gra-1905	52	9	24.33	24.33	NUM
gra-1905	52	10	±	±	NUM
gra-1905	52	11	6.64	6.64	NUM
gra-1905	52	12	kg	kg	NOUN
gra-1905	52	13	/	/	SYM
gra-1905	52	14	m	m	PROPN
gra-1905	52	15	while	while	SCONJ
gra-1905	52	16	2	2	NUM
gra-1905	52	17	in	in	ADP
gra-1905	52	18	case	case	NOUN
gra-1905	52	19	of	of	ADP
gra-1905	52	20	females	female	NOUN
gra-1905	52	21	it	it	PRON
gra-1905	52	22	was	be	AUX
gra-1905	52	23	30.07	30.07	NUM
gra-1905	52	24	±	±	NUM
gra-1905	52	25	6.95	6.95	NUM
gra-1905	52	26	kg	kg	NOUN
gra-1905	52	27	/	/	SYM
gra-1905	52	28	m	m	NOUN
gra-1905	52	29	.	.	PUNCT
gra-1905	53	1	overall	overall	ADJ
gra-1905	53	2	mean	mean	VERB
gra-1905	53	3	bmi	bmi	PROPN
gra-1905	53	4	2of	2of	PROPN
gra-1905	53	5	study	study	NOUN
gra-1905	53	6	population	population	NOUN
gra-1905	53	7	was	be	AUX
gra-1905	53	8	26.22	26.22	NUM
gra-1905	53	9	±	±	NUM
gra-1905	53	10	7.22	7.22	NUM
gra-1905	53	11	kg	kg	NOUN
gra-1905	53	12	/	/	SYM
gra-1905	53	13	m	m	PROPN
gra-1905	53	14	,	,	PUNCT
gra-1905	53	15	similar	similar	ADJ
gra-1905	53	16	to	to	ADP
gra-1905	53	17	emel	emel	PROPN
gra-1905	53	18	11	11	NUM
gra-1905	53	19	12bulcun	12bulcun	NUM
gra-1905	53	20	et	et	PROPN
gra-1905	53	21	al	al	PROPN
gra-1905	53	22	and	and	CCONJ
gra-1905	53	23	z.yasar	z.yasar	PROPN
gra-1905	53	24	et	et	PROPN
gra-1905	53	25	al	al	PROPN
gra-1905	53	26	.	.	PUNCT
gra-1905	54	1	conclusion	conclusion	NOUN
gra-1905	54	2	metabolic	metabolic	NOUN
gra-1905	54	3	syndrome	syndrome	NOUN
gra-1905	54	4	is	be	AUX
gra-1905	54	5	more	more	ADV
gra-1905	54	6	common	common	ADJ
gra-1905	54	7	in	in	ADP
gra-1905	54	8	copd	copd	NOUN
gra-1905	54	9	patients	patient	NOUN
gra-1905	54	10	leading	lead	VERB
gra-1905	54	11	to	to	ADP
gra-1905	54	12	signicant	signicant	ADJ
gra-1905	54	13	morbidity	morbidity	NOUN
gra-1905	54	14	and	and	CCONJ
gra-1905	54	15	mortality	mortality	NOUN
gra-1905	54	16	.	.	PUNCT
gra-1905	55	1	thus	thus	ADV
gra-1905	55	2	,	,	PUNCT
gra-1905	55	3	it	it	PRON
gra-1905	55	4	is	be	AUX
gra-1905	55	5	essential	essential	ADJ
gra-1905	55	6	to	to	PART
gra-1905	55	7	focus	focus	VERB
gra-1905	55	8	on	on	ADP
gra-1905	55	9	a	a	DET
gra-1905	55	10	comprehensive	comprehensive	ADJ
gra-1905	55	11	way	way	NOUN
gra-1905	55	12	of	of	ADP
gra-1905	55	13	management	management	NOUN
gra-1905	55	14	of	of	ADP
gra-1905	55	15	copd	copd	PROPN
gra-1905	55	16	and	and	CCONJ
gra-1905	55	17	its	its	PRON
gra-1905	55	18	comorbidities	comorbiditie	NOUN
gra-1905	55	19	rather	rather	ADV
gra-1905	55	20	than	than	ADP
gra-1905	55	21	primarily	primarily	ADV
gra-1905	55	22	treating	treat	VERB
gra-1905	55	23	the	the	DET
gra-1905	55	24	pulmonary	pulmonary	ADJ
gra-1905	55	25	symptoms	symptom	NOUN
gra-1905	55	26	.	.	PUNCT
gra-1905	56	1	references	reference	NOUN
gra-1905	56	2	:	:	PUNCT
gra-1905	56	3	1	1	X
gra-1905	56	4	.	.	X
gra-1905	56	5	global	global	ADJ
gra-1905	56	6	initiative	initiative	NOUN
gra-1905	56	7	for	for	ADP
gra-1905	56	8	chronic	chronic	ADJ
gra-1905	56	9	obstructive	obstructive	ADJ
gra-1905	56	10	lung	lung	NOUN
gra-1905	56	11	disease	disease	NOUN
gra-1905	56	12	(	(	PUNCT
gra-1905	56	13	gold	gold	NOUN
gra-1905	56	14	)	)	PUNCT
gra-1905	56	15	.	.	PUNCT
gra-1905	57	1	gold	gold	NOUN
gra-1905	57	2	2017	2017	NUM
gra-1905	57	3	global	global	ADJ
gra-1905	57	4	strategy	strategy	NOUN
gra-1905	57	5	for	for	ADP
gra-1905	57	6	the	the	DET
gra-1905	57	7	diagnosis	diagnosis	NOUN
gra-1905	57	8	,	,	PUNCT
gra-1905	57	9	management	management	NOUN
gra-1905	57	10	,	,	PUNCT
gra-1905	57	11	and	and	CCONJ
gra-1905	57	12	prevention	prevention	NOUN
gra-1905	57	13	of	of	ADP
gra-1905	57	14	chronic	chronic	ADJ
gra-1905	57	15	obstructive	obstructive	ADJ
gra-1905	57	16	pulmonary	pulmonary	ADJ
gra-1905	57	17	disease	disease	NOUN
gra-1905	57	18	,	,	PUNCT
gra-1905	57	19	2017	2017	NUM
gra-1905	57	20	report	report	NOUN
gra-1905	57	21	.	.	PUNCT
gra-1905	58	1	2	2	X
gra-1905	58	2	.	.	X
gra-1905	58	3	steuten	steuten	PROPN
gra-1905	58	4	lm	lm	PROPN
gra-1905	58	5	,	,	PUNCT
gra-1905	58	6	creutzberg	creutzberg	PROPN
gra-1905	58	7	ec	ec	PROPN
gra-1905	58	8	,	,	PUNCT
gra-1905	58	9	vrijhoef	vrijhoef	PROPN
gra-1905	58	10	hj	hj	PROPN
gra-1905	58	11	,	,	PUNCT
gra-1905	58	12	wouters	wouters	PROPN
gra-1905	58	13	ef	ef	PROPN
gra-1905	58	14	.	.	PUNCT
gra-1905	58	15	copd	copd	PROPN
gra-1905	58	16	as	as	ADP
gra-1905	58	17	a	a	DET
gra-1905	58	18	multico	multico	NOUN
gra-1905	58	19	mponent	mponent	NOUN
gra-1905	58	20	disease	disease	NOUN
gra-1905	58	21	:	:	PUNCT
gra-1905	58	22	inventory	inventory	NOUN
gra-1905	58	23	of	of	ADP
gra-1905	58	24	dyspnoea	dyspnoea	PROPN
gra-1905	58	25	,	,	PUNCT
gra-1905	58	26	underweight	underweight	NOUN
gra-1905	58	27	,	,	PUNCT
gra-1905	58	28	obesity	obesity	NOUN
gra-1905	58	29	and	and	CCONJ
gra-1905	58	30	fat	fat	NOUN
gra-1905	58	31	free	free	ADJ
gra-1905	58	32	mass	mass	NOUN
gra-1905	58	33	depletion	depletion	NOUN
gra-1905	58	34	in	in	ADP
gra-1905	58	35	primary	primary	ADJ
gra-1905	58	36	care	care	NOUN
gra-1905	58	37	.	.	PUNCT
gra-1905	59	1	pri	pri	PROPN
gra-1905	59	2	care	care	PROPN
gra-1905	59	3	resp	resp	PROPN
gra-1905	59	4	j.	j.	PROPN
gra-1905	59	5	2006	2006	NUM
gra-1905	59	6	apr	apr	PROPN
gra-1905	59	7	1;15(2):84	1;15(2):84	NUM
gra-1905	59	8	-	-	SYM
gra-1905	59	9	91	91	NUM
gra-1905	59	10	.	.	PUNCT
gra-1905	60	1	3	3	X
gra-1905	60	2	.	.	X
gra-1905	60	3	park	park	NOUN
gra-1905	60	4	sk	sk	PROPN
gra-1905	60	5	,	,	PUNCT
gra-1905	60	6	larson	larson	PROPN
gra-1905	60	7	jl	jl	PROPN
gra-1905	60	8	.	.	PUNCT
gra-1905	60	9	metabolic	metabolic	PROPN
gra-1905	60	10	syndrome	syndrome	PROPN
gra-1905	60	11	and	and	CCONJ
gra-1905	60	12	associated	associated	ADJ
gra-1905	60	13	factors	factor	NOUN
gra-1905	60	14	in	in	ADP
gra-1905	60	15	people	people	NOUN
gra-1905	60	16	with	with	ADP
gra-1905	60	17	chronic	chronic	ADJ
gra-1905	60	18	obstructive	obstructive	ADJ
gra-1905	60	19	pulmonary	pulmonary	ADJ
gra-1905	60	20	disease	disease	NOUN
gra-1905	60	21	.	.	PUNCT
gra-1905	61	1	west	west	PROPN
gra-1905	61	2	j	j	PROPN
gra-1905	61	3	nursing	nursing	NOUN
gra-1905	61	4	res	re	NOUN
gra-1905	61	5	.	.	PUNCT
gra-1905	61	6	2014	2014	NUM
gra-1905	62	1	may;36(5):620	may;36(5):620	PROPN
gra-1905	62	2	-	-	PUNCT
gra-1905	62	3	42	42	NUM
gra-1905	62	4	.	.	PUNCT
gra-1905	63	1	4	4	X
gra-1905	63	2	.	.	X
gra-1905	63	3	poulain	poulain	PROPN
gra-1905	63	4	m	m	PROPN
gra-1905	63	5	,	,	PUNCT
gra-1905	63	6	doucet	doucet	PROPN
gra-1905	63	7	m	m	PROPN
gra-1905	63	8	,	,	PUNCT
gra-1905	63	9	drapeau	drapeau	PROPN
gra-1905	63	10	v	v	PROPN
gra-1905	63	11	,	,	PUNCT
gra-1905	63	12	fournier	fournier	PROPN
gra-1905	63	13	g	g	PROPN
gra-1905	63	14	,	,	PUNCT
gra-1905	63	15	tremblay	tremblay	VERB
gra-1905	63	16	a	a	DET
gra-1905	63	17	,	,	PUNCT
gra-1905	63	18	poirier	poirier	PROPN
gra-1905	63	19	p	p	PROPN
gra-1905	63	20	,	,	PUNCT
gra-1905	63	21	et	et	PROPN
gra-1905	63	22	al	al	PROPN
gra-1905	63	23	.	.	PROPN
gra-1905	63	24	metabolic	metabolic	PROPN
gra-1905	63	25	and	and	CCONJ
gra-1905	63	26	inammatory	inammatory	PROPN
gra-1905	63	27	prole	prole	PROPN
gra-1905	63	28	in	in	ADP
gra-1905	63	29	obese	obese	ADJ
gra-1905	63	30	patients	patient	NOUN
gra-1905	63	31	with	with	ADP
gra-1905	63	32	chronic	chronic	ADJ
gra-1905	63	33	obstructive	obstructive	ADJ
gra-1905	63	34	pulmonary	pulmonary	ADJ
gra-1905	63	35	disease	disease	NOUN
gra-1905	63	36	.	.	PUNCT
gra-1905	64	1	chronic	chronic	ADJ
gra-1905	64	2	resp	resp	PROPN
gra-1905	64	3	dis	dis	PROPN
gra-1905	64	4	.	.	PROPN
gra-1905	64	5	2008	2008	NUM
gra-1905	64	6	feb;5(1):35	feb;5(1):35	PROPN
gra-1905	64	7	-	-	PUNCT
gra-1905	64	8	41	41	NUM
gra-1905	64	9	.	.	PUNCT
gra-1905	64	10	5	5	NUM
gra-1905	64	11	.	.	X
gra-1905	64	12	tanni	tanni	PROPN
gra-1905	64	13	se	se	PROPN
gra-1905	64	14	,	,	PUNCT
gra-1905	64	15	zamuner	zamuner	NOUN
gra-1905	64	16	at	at	ADP
gra-1905	64	17	,	,	PUNCT
gra-1905	64	18	coelho	coelho	PROPN
gra-1905	64	19	ls	ls	PROPN
gra-1905	64	20	,	,	PUNCT
gra-1905	64	21	vale	vale	PROPN
gra-1905	64	22	sa	sa	PROPN
gra-1905	64	23	,	,	PUNCT
gra-1905	64	24	godoy	godoy	PROPN
gra-1905	64	25	i	i	PROPN
gra-1905	64	26	,	,	PUNCT
gra-1905	64	27	paiva	paiva	PROPN
gra-1905	64	28	sa	sa	PROPN
gra-1905	64	29	.	.	PROPN
gra-1905	64	30	are	be	AUX
gra-1905	64	31	metabolic	metabolic	NOUN
gra-1905	64	32	syndrome	syndrome	NOUN
gra-1905	64	33	and	and	CCONJ
gra-1905	64	34	its	its	PRON
gra-1905	64	35	components	component	NOUN
gra-1905	64	36	associated	associate	VERB
gra-1905	64	37	with	with	ADP
gra-1905	64	38	5	5	NUM
gra-1905	64	39	-	-	PUNCT
gra-1905	64	40	year	year	NOUN
gra-1905	64	41	mortality	mortality	NOUN
gra-1905	64	42	in	in	ADP
gra-1905	64	43	chronic	chronic	ADJ
gra-1905	64	44	obstructive	obstructive	ADJ
gra-1905	64	45	pupmonary	pupmonary	ADJ
gra-1905	64	46	disease	disease	NOUN
gra-1905	64	47	patients	patient	NOUN
gra-1905	64	48	?	?	PUNCT
gra-1905	64	49	.	.	PUNCT
gra-1905	65	1	metab	metab	PROPN
gra-1905	65	2	syndrome	syndrome	NOUN
gra-1905	65	3	related	relate	VERB
gra-1905	65	4	disord	disord	NOUN
gra-1905	65	5	.	.	PUNCT
gra-1905	66	1	2015	2015	NUM
gra-1905	66	2	feb	feb	NOUN
gra-1905	66	3	1;13(1):52	1;13(1):52	NUM
gra-1905	66	4	-	-	SYM
gra-1905	66	5	4	4	NUM
gra-1905	66	6	.	.	NOUN
gra-1905	66	7	6	6	NUM
gra-1905	66	8	.	.	X
gra-1905	66	9	lopez	lopez	NOUN
gra-1905	66	10	ad	ad	NOUN
gra-1905	66	11	,	,	PUNCT
gra-1905	66	12	shibuya	shibuya	PROPN
gra-1905	66	13	k	k	PROPN
gra-1905	66	14	,	,	PUNCT
gra-1905	66	15	rao	rao	PROPN
gra-1905	66	16	c	c	PROPN
gra-1905	66	17	,	,	PUNCT
gra-1905	66	18	mathers	mathers	PROPN
gra-1905	66	19	cd	cd	PROPN
gra-1905	66	20	,	,	PUNCT
gra-1905	66	21	hansell	hansell	PROPN
gra-1905	66	22	al	al	PROPN
gra-1905	66	23	,	,	PUNCT
gra-1905	66	24	held	hold	VERB
gra-1905	66	25	ls	ls	PROPN
gra-1905	66	26	,	,	PUNCT
gra-1905	66	27	et	et	PROPN
gra-1905	66	28	al	al	PROPN
gra-1905	66	29	.	.	PROPN
gra-1905	66	30	chronic	chronic	ADJ
gra-1905	66	31	obstructive	obstructive	ADJ
gra-1905	66	32	pulmonary	pulmonary	ADJ
gra-1905	66	33	disease	disease	NOUN
gra-1905	66	34	:	:	PUNCT
gra-1905	66	35	current	current	ADJ
gra-1905	66	36	burden	burden	NOUN
gra-1905	66	37	and	and	CCONJ
gra-1905	66	38	future	future	ADJ
gra-1905	66	39	projections	projection	NOUN
gra-1905	66	40	.	.	PUNCT
gra-1905	67	1	euro	euro	PROPN
gra-1905	67	2	res	res	PROPN
gra-1905	67	3	j.	j.	PROPN
gra-1905	67	4	2006	2006	NUM
gra-1905	67	5	feb	feb	PROPN
gra-1905	67	6	1;27(2):397	1;27(2):397	NUM
gra-1905	67	7	-	-	SYM
gra-1905	67	8	412	412	NUM
gra-1905	67	9	.	.	NOUN
gra-1905	67	10	7	7	X
gra-1905	67	11	.	.	X
gra-1905	67	12	zimmet	zimmet	NOUN
gra-1905	67	13	p	p	NOUN
gra-1905	67	14	,	,	PUNCT
gra-1905	67	15	magliano	magliano	PROPN
gra-1905	67	16	d	d	PROPN
gra-1905	67	17	,	,	PUNCT
gra-1905	67	18	matsuzawa	matsuzawa	PROPN
gra-1905	67	19	y	y	PROPN
gra-1905	67	20	,	,	PUNCT
gra-1905	67	21	alberti	alberti	VERB
gra-1905	67	22	g	g	PROPN
gra-1905	67	23	,	,	PUNCT
gra-1905	67	24	shaw	shaw	PROPN
gra-1905	67	25	j.	j.	PROPN
gra-1905	67	26	the	the	DET
gra-1905	67	27	metabolic	metabolic	NOUN
gra-1905	67	28	syndrome	syndrome	NOUN
gra-1905	67	29	:	:	PUNCT
gra-1905	67	30	a	a	DET
gra-1905	67	31	global	global	ADJ
gra-1905	67	32	public	public	ADJ
gra-1905	67	33	health	health	NOUN
gra-1905	67	34	problem	problem	NOUN
gra-1905	67	35	and	and	CCONJ
gra-1905	67	36	a	a	DET
gra-1905	67	37	new	new	ADJ
gra-1905	67	38	denition	denition	NOUN
gra-1905	67	39	.	.	PUNCT
gra-1905	68	1	j	j	PROPN
gra-1905	68	2	atheroscler	atheroscler	PROPN
gra-1905	68	3	thrombosis	thrombosis	NOUN
gra-1905	68	4	.	.	PUNCT
gra-1905	69	1	2005;12(6):295	2005;12(6):295	NUM
gra-1905	69	2	-	-	SYM
gra-1905	69	3	300	300	NUM
gra-1905	69	4	.	.	NOUN
gra-1905	69	5	8	8	NUM
gra-1905	69	6	.	.	X
gra-1905	69	7	henrik	henrik	PROPN
gra-1905	69	8	watz	watz	PROPN
gra-1905	69	9	,	,	PUNCT
gra-1905	69	10	benjamin	benjamin	PROPN
gra-1905	69	11	waschki	waschki	PROPN
gra-1905	69	12	,	,	PUNCT
gra-1905	69	13	anne	anne	PROPN
gra-1905	69	14	kirsten	kirsten	PROPN
gra-1905	69	15	,	,	PUNCT
gra-1905	69	16	kai	kai	PROPN
gra-1905	69	17	-	-	PUNCT
gra-1905	69	18	christian	christian	PROPN
gra-1905	69	19	mu¨ller	mu¨ller	PUNCT
gra-1905	69	20	;	;	PUNCT
gra-1905	69	21	gunther	gunther	PROPN
gra-1905	69	22	kretschmar	kretschmar	PROPN
gra-1905	69	23	,	,	PUNCT
gra-1905	69	24	thorsten	thorsten	PROPN
gra-1905	69	25	meyer	meyer	PROPN
gra-1905	69	26	,	,	PUNCT
gra-1905	69	27	olaf	olaf	PROPN
gra-1905	69	28	holz	holz	PROPN
gra-1905	69	29	,	,	PUNCT
gra-1905	69	30	helgomagnussen	helgomagnussen	PROPN
gra-1905	69	31	.	.	PUNCT
gra-1905	70	1	the	the	DET
gra-1905	70	2	metabolic	metabolic	NOUN
gra-1905	70	3	syndrome	syndrome	NOUN
gra-1905	70	4	in	in	ADP
gra-1905	70	5	patients	patient	NOUN
gra-1905	70	6	with	with	ADP
gra-1905	70	7	chronic	chronic	ADJ
gra-1905	70	8	bronchitis	bronchitis	NOUN
gra-1905	70	9	and	and	CCONJ
gra-1905	70	10	copd	copd	NOUN
gra-1905	70	11	.	.	PUNCT
gra-1905	71	1	2009	2009	NUM
gra-1905	71	2	chest	chest	NOUN
gra-1905	71	3	;	;	PUNCT
gra-1905	71	4	136	136	NUM
gra-1905	71	5	(	(	PUNCT
gra-1905	71	6	4):1039	4):1039	NOUN
gra-1905	71	7	9	9	NUM
gra-1905	71	8	.	.	X
gra-1905	71	9	jesús	jesús	ADJ
gra-1905	71	10	díez	díez	PROPN
gra-1905	71	11	manglano	manglano	PROPN
gra-1905	71	12	,	,	PUNCT
gra-1905	71	13	josé	josé	PROPN
gra-1905	71	14	barquero	barquero	PROPN
gra-1905	71	15	-	-	PUNCT
gra-1905	71	16	romero	romero	PROPN
gra-1905	71	17	,	,	PUNCT
gra-1905	71	18	pedro	pedro	PROPN
gra-1905	71	19	almagro	almagro	PROPN
gra-1905	71	20	,	,	PUNCT
gra-1905	71	21	f.	f.	PROPN
gra-1905	71	22	javier	javier	PROPN
gra-1905	71	23	cabrera	cabrera	PROPN
gra-1905	71	24	,	,	PUNCT
gra-1905	71	25	francisco	francisco	PROPN
gra-1905	71	26	lópez	lópez	PROPN
gra-1905	71	27	garcía	garcía	PROPN
gra-1905	71	28	,	,	PUNCT
gra-1905	71	29	lorena	lorena	PROPN
gra-1905	71	30	montero	montero	PROPN
gra-1905	71	31	,	,	PUNCT
gra-1905	71	32	joan	joan	PROPN
gra-1905	71	33	b.	b.	PROPN
gra-1905	71	34	soriano	soriano	PROPN
gra-1905	71	35	.	.	PUNCT
gra-1905	72	1	copd	copd	PROPN
gra-1905	72	2	patients	patient	NOUN
gra-1905	72	3	with	with	ADP
gra-1905	72	4	and	and	CCONJ
gra-1905	72	5	without	without	ADP
gra-1905	72	6	metabolic	metabolic	NOUN
gra-1905	72	7	syndrome	syndrome	NOUN
gra-1905	72	8	:	:	PUNCT
gra-1905	72	9	clinical	clinical	ADJ
gra-1905	72	10	and	and	CCONJ
gra-1905	72	11	functional	functional	ADJ
gra-1905	72	12	differences	difference	NOUN
gra-1905	72	13	.	.	PUNCT
gra-1905	73	1	internal	internal	ADJ
gra-1905	73	2	and	and	CCONJ
gra-1905	73	3	emergncy	emergncy	ADJ
gra-1905	73	4	medicine	medicine	NOUN
gra-1905	73	5	.	.	PUNCT
gra-1905	74	1	2013;1	2013;1	NUM
gra-1905	74	2	-	-	SYM
gra-1905	74	3	27	27	NUM
gra-1905	74	4	10	10	NUM
gra-1905	74	5	.	.	PUNCT
gra-1905	75	1	karine	karine	PROPN
gra-1905	75	2	marquis	marquis	PROPN
gra-1905	75	3	,	,	PUNCT
gra-1905	75	4	françois	françois	PROPN
gra-1905	75	5	maltais	maltais	PROPN
gra-1905	75	6	,	,	PUNCT
gra-1905	75	7	véronique	véronique	ADJ
gra-1905	75	8	duguay	duguay	NOUN
gra-1905	75	9	,	,	PUNCT
gra-1905	75	10	anne	anne	PROPN
gra-1905	75	11	-	-	PUNCT
gra-1905	75	12	marie	marie	PROPN
gra-1905	75	13	bezeau	bezeau	PROPN
gra-1905	75	14	,	,	PUNCT
gra-1905	75	15	picrre	picrre	NOUN
gra-1905	75	16	le	le	X
gra-1905	75	17	blanc	blanc	PROPN
gra-1905	75	18	,	,	PUNCT
gra-1905	75	19	jcan	jcan	PROPN
gra-1905	75	20	jobin	jobin	PROPN
gra-1905	75	21	,	,	PUNCT
gra-1905	75	22	paul	paul	PROPN
gra-1905	75	23	poirier	poirier	PROPN
gra-1905	75	24	.	.	PUNCT
gra-1905	76	1	the	the	DET
gra-1905	76	2	metabolic	metabolic	NOUN
gra-1905	76	3	syndrome	syndrome	NOUN
gra-1905	76	4	in	in	ADP
gra-1905	76	5	patients	patient	NOUN
gra-1905	76	6	with	with	ADP
gra-1905	76	7	chronic	chronic	ADJ
gra-1905	76	8	obstructive	obstructive	ADJ
gra-1905	76	9	pulmonary	pulmonary	ADJ
gra-1905	76	10	disease	disease	NOUN
gra-1905	76	11	.	.	PUNCT
gra-1905	77	1	journal	journal	NOUN
gra-1905	77	2	of	of	ADP
gra-1905	77	3	cardiopulmonary	cardiopulmonary	ADJ
gra-1905	77	4	rehabilitation	rehabilitation	NOUN
gra-1905	77	5	.	.	PUNCT
gra-1905	78	1	2005;25:226	2005;25:226	NUM
gra-1905	78	2	-	-	SYM
gra-1905	78	3	232	232	NUM
gra-1905	78	4	11	11	NUM
gra-1905	78	5	.	.	PUNCT
gra-1905	79	1	emel	emel	PROPN
gra-1905	79	2	bulcun	bulcun	PROPN
gra-1905	79	3	,	,	PUNCT
gra-1905	79	4	aydanur	aydanur	NOUN
gra-1905	79	5	ekici	ekici	PROPN
gra-1905	79	6	,	,	PUNCT
gra-1905	79	7	mehmet	mehmet	PROPN
gra-1905	79	8	ekici	ekici	PROPN
gra-1905	79	9	.	.	PUNCT
gra-1905	80	1	metabolic	metabolic	NOUN
gra-1905	80	2	syndrome	syndrome	NOUN
gra-1905	80	3	and	and	CCONJ
gra-1905	80	4	chronic	chronic	ADJ
gra-1905	80	5	diseases	disease	NOUN
gra-1905	80	6	in	in	ADP
gra-1905	80	7	patients	patient	NOUN
gra-1905	80	8	with	with	ADP
gra-1905	80	9	chronic	chronic	ADJ
gra-1905	80	10	obstructive	obstructive	ADJ
gra-1905	80	11	pulmonary	pulmonary	ADJ
gra-1905	80	12	disease	disease	NOUN
gra-1905	80	13	.	.	PUNCT
gra-1905	81	1	i̇zmir	i̇zmir	PROPN
gra-1905	81	2	göğüs	göğüs	VERB
gra-1905	81	3	hospital	hospital	NOUN
gra-1905	81	4	journal.2015	journal.2015	PROPN
gra-1905	81	5	;	;	PUNCT
gra-1905	81	6	29:1	29:1	NUM
gra-1905	81	7	-	-	SYM
gra-1905	81	8	10	10	NUM
gra-1905	81	9	12	12	NUM
gra-1905	81	10	.	.	PUNCT
gra-1905	82	1	z.yasar	z.yasar	NUM
gra-1905	82	2	,	,	PUNCT
gra-1905	82	3	m.	m.	NOUN
gra-1905	82	4	buyuksirin	buyuksirin	PROPN
gra-1905	82	5	,	,	PUNCT
gra-1905	82	6	f.d	f.d	PROPN
gra-1905	82	7	.	.	PROPN
gra-1905	82	8	ucsular	ucsular	ADJ
gra-1905	82	9	,	,	PUNCT
gra-1905	82	10	a.kargi	a.kargi	NOUN
gra-1905	82	11	,	,	PUNCT
gra-1905	82	12	f.erdem	f.erdem	NOUN
gra-1905	82	13	,	,	PUNCT
gra-1905	82	14	f.	f.	PROPN
gra-1905	82	15	talay	talay	PROPN
gra-1905	82	16	,	,	PUNCT
gra-1905	82	17	o.k	o.k	PROPN
gra-1905	82	18	.	.	PROPN
gra-1905	82	19	kurt	kurt	PROPN
gra-1905	82	20	.	.	PUNCT
gra-1905	83	1	is	be	AUX
gra-1905	83	2	an	an	DET
gra-1905	83	3	elevated	elevated	ADJ
gra-1905	83	4	neutrophil	neutrophil	NOUN
gra-1905	83	5	-	-	PUNCT
gra-1905	83	6	to	to	ADP
gra-1905	83	7	-	-	PUNCT
gra-1905	83	8	lymphocyte	lymphocyte	NOUN
gra-1905	83	9	ratio	ratio	NOUN
gra-1905	83	10	a	a	DET
gra-1905	83	11	predictor	predictor	NOUN
gra-1905	83	12	of	of	ADP
gra-1905	83	13	metabolic	metabolic	NOUN
gra-1905	83	14	syndrome	syndrome	NOUN
gra-1905	83	15	in	in	ADP
gra-1905	83	16	patientswith	patientswith	NOUN
gra-1905	83	17	chronic	chronic	ADJ
gra-1905	83	18	obstructive	obstructive	ADJ
gra-1905	83	19	pulmonary	pulmonary	ADJ
gra-1905	83	20	disease	disease	NOUN
gra-1905	83	21	?	?	PUNCT
gra-1905	84	1	european	european	PROPN
gra-1905	84	2	review	review	PROPN
gra-1905	84	3	for	for	ADP
gra-1905	84	4	medical	medical	ADJ
gra-1905	84	5	and	and	CCONJ
gra-1905	84	6	pharmacological	pharmacological	ADJ
gra-1905	84	7	sciences	science	NOUN
gra-1905	84	8	.	.	PUNCT
gra-1905	85	1	2015;19:956	2015;19:956	NUM
gra-1905	85	2	-	-	SYM
gra-1905	85	3	962	962	NUM
gra-1905	85	4	volume-9	volume-9	NUM
gra-1905	85	5	,	,	PUNCT
gra-1905	85	6	issue-2	issue-2	PROPN
gra-1905	85	7	,	,	PUNCT
gra-1905	85	8	february-2020	february-2020	VERB
gra-1905	85	9	•	•	NUM
gra-1905	85	10	print	print	NOUN
gra-1905	85	11	issn	issn	PROPN
gra-1905	85	12	no	no	NOUN
gra-1905	85	13	.	.	PROPN
gra-1905	86	1	2277	2277	NUM
gra-1905	86	2	8160	8160	NUM
gra-1905	86	3	•	•	NOUN
gra-1905	86	4	doi	doi	NOUN
gra-1905	86	5	:	:	PUNCT
gra-1905	86	6	10.36106	10.36106	NUM
gra-1905	86	7	/	/	SYM
gra-1905	86	8	gjra	gjra	NOUN
gra-1905	86	9	table-1	table-1	NUM
gra-1905	86	10	:	:	PUNCT
gra-1905	86	11	comparision	comparision	NOUN
gra-1905	86	12	of	of	ADP
gra-1905	86	13	various	various	ADJ
gra-1905	86	14	parameters	parameter	NOUN
gra-1905	86	15	between	between	ADP
gra-1905	86	16	mets	met	NOUN
gra-1905	86	17	and	and	CCONJ
gra-1905	86	18	non	non	ADJ
gra-1905	86	19	-	-	ADJ
gra-1905	86	20	mets	met	NOUN
gra-1905	86	21	copd	copd	NOUN
gra-1905	86	22	patients	patient	NOUN
gra-1905	86	23	.	.	PUNCT
gra-1905	87	1	parameter	parameter	PROPN
gra-1905	87	2	copd	copd	PROPN
gra-1905	87	3	with	with	ADP
gra-1905	87	4	metabolic	metabolic	NOUN
gra-1905	87	5	syndrome	syndrome	NOUN
gra-1905	87	6	(	(	PUNCT
gra-1905	87	7	n=20	n=20	NOUN
gra-1905	87	8	)	)	PUNCT
gra-1905	87	9	copd	copd	NOUN
gra-1905	87	10	without	without	ADP
gra-1905	87	11	metabolic	metabolic	NOUN
gra-1905	87	12	syndrome	syndrome	NOUN
gra-1905	87	13	(	(	PUNCT
gra-1905	87	14	n=47	n=47	PROPN
gra-1905	87	15	)	)	PUNCT
gra-1905	87	16	name	name	NOUN
gra-1905	87	17	of	of	ADP
gra-1905	87	18	test	test	NOUN
gra-1905	87	19	(	(	PUNCT
gra-1905	87	20	student	student	NOUN
gra-1905	87	21	t	t	PROPN
gra-1905	87	22	test	test	NOUN
gra-1905	87	23	)	)	PUNCT
gra-1905	88	1	p	p	NOUN
gra-1905	88	2	value	value	NOUN
gra-1905	88	3	signicant/	signicant/	X
gra-1905	88	4	non	non	ADJ
gra-1905	88	5	-	-	ADJ
gra-1905	88	6	signicant	signicant	ADJ
gra-1905	88	7	waist	waist	NOUN
gra-1905	88	8	circumference	circumference	NOUN
gra-1905	88	9	101	101	NUM
gra-1905	88	10	±	±	NUM
gra-1905	88	11	11.17	11.17	NUM
gra-1905	88	12	81.30	81.30	NUM
gra-1905	88	13	±	±	NUM
gra-1905	88	14	10.86	10.86	NUM
gra-1905	88	15	2.0047	2.0047	NUM
gra-1905	88	16	0.329	0.329	NUM
gra-1905	88	17	not	not	PART
gra-1905	88	18	signicant	signicant	ADJ
gra-1905	88	19	tg	tg	PROPN
gra-1905	88	20	202.26	202.26	NUM
gra-1905	88	21	±	±	NUM
gra-1905	88	22	97.72	97.72	NUM
gra-1905	88	23	140.86	140.86	NUM
gra-1905	88	24	±	±	NUM
gra-1905	88	25	94.81	94.81	NUM
gra-1905	88	26	2.0287	2.0287	NUM
gra-1905	88	27	0.41	0.41	NUM
gra-1905	88	28	not	not	PART
gra-1905	88	29	signicant	signicant	ADJ
gra-1905	88	30	hdl	hdl	PROPN
gra-1905	89	1	50.26	50.26	NUM
gra-1905	89	2	±	±	NUM
gra-1905	89	3	12.12	12.12	NUM
gra-1905	89	4	54.77	54.77	NUM
gra-1905	89	5	±	±	NUM
gra-1905	89	6	12.76	12.76	NUM
gra-1905	89	7	2.0094	2.0094	NUM
gra-1905	89	8	0.592	0.592	NUM
gra-1905	89	9	not	not	PART
gra-1905	89	10	signicant	signicant	ADJ
gra-1905	89	11	fasting	fast	VERB
gra-1905	89	12	blood	blood	NOUN
gra-1905	89	13	sugar	sugar	NOUN
gra-1905	89	14	133.22	133.22	NUM
gra-1905	89	15	±	±	NUM
gra-1905	89	16	21.06	21.06	NUM
gra-1905	89	17	99.39	99.39	NUM
gra-1905	89	18	±	±	NUM
gra-1905	89	19	20.06	20.06	NUM
gra-1905	89	20	2.0223	2.0223	NUM
gra-1905	89	21	0.381	0.381	NUM
gra-1905	89	22	not	not	PART
gra-1905	89	23	signicant	signicant	ADJ
gra-1905	89	24	systolic	systolic	ADJ
gra-1905	89	25	bp	bp	PROPN
gra-1905	89	26	148.09	148.09	NUM
gra-1905	89	27	±	±	NUM
gra-1905	89	28	29.31	29.31	NUM
gra-1905	89	29	126.41	126.41	NUM
gra-1905	89	30	±	±	NUM
gra-1905	89	31	15.34	15.34	NUM
gra-1905	89	32	2.0527	2.0527	NUM
gra-1905	89	33	0.0001	0.0001	NUM
gra-1905	89	34	signicant	signicant	ADJ
gra-1905	89	35	by	by	ADP
gra-1905	89	36	ldl	ldl	NOUN
gra-1905	89	37	(	(	PUNCT
gra-1905	89	38	63.2	63.2	NUM
gra-1905	89	39	%	%	NOUN
gra-1905	89	40	)	)	PUNCT
gra-1905	89	41	and	and	CCONJ
gra-1905	89	42	total	total	ADJ
gra-1905	89	43	cholesterol	cholesterol	NOUN
gra-1905	89	44	(	(	PUNCT
gra-1905	89	45	63.2	63.2	NUM
gra-1905	89	46	%	%	NOUN
gra-1905	89	47	)	)	PUNCT
gra-1905	89	48	.	.	PUNCT
gra-1905	90	1	in	in	ADP
gra-1905	90	2	female	female	ADJ
gra-1905	90	3	hdl	hdl	PROPN
gra-1905	90	4	was	be	AUX
gra-1905	90	5	decreased	decrease	VERB
gra-1905	90	6	in	in	ADP
gra-1905	90	7	majority	majority	NOUN
gra-1905	90	8	(	(	PUNCT
gra-1905	90	9	58.3	58.3	NUM
gra-1905	90	10	%	%	NOUN
gra-1905	90	11	)	)	PUNCT
gra-1905	90	12	followed	follow	VERB
gra-1905	90	13	by	by	ADP
gra-1905	90	14	ldl	ldl	NOUN
gra-1905	90	15	(	(	PUNCT
gra-1905	90	16	36.8	36.8	NUM
gra-1905	90	17	%	%	NOUN
gra-1905	90	18	)	)	PUNCT
gra-1905	90	19	and	and	CCONJ
gra-1905	90	20	total	total	ADJ
gra-1905	90	21	cholesterol	cholesterol	NOUN
gra-1905	90	22	(	(	PUNCT
gra-1905	90	23	36.8	36.8	NUM
gra-1905	90	24	%	%	NOUN
gra-1905	90	25	)	)	PUNCT
gra-1905	90	26	.	.	PUNCT
gra-1905	91	1	raised	raise	VERB
gra-1905	91	2	fasting	fast	VERB
gra-1905	91	3	blood	blood	NOUN
gra-1905	91	4	sugar	sugar	NOUN
gra-1905	91	5	(	(	PUNCT
gra-1905	91	6	fbs	fbs	PROPN
gra-1905	91	7	)	)	PUNCT
gra-1905	91	8	was	be	AUX
gra-1905	91	9	more	more	ADV
gra-1905	91	10	in	in	ADP
gra-1905	91	11	female	female	ADJ
gra-1905	91	12	(	(	PUNCT
gra-1905	91	13	54.5	54.5	NUM
gra-1905	91	14	%	%	NOUN
gra-1905	91	15	)	)	PUNCT
gra-1905	91	16	than	than	ADP
gra-1905	91	17	males	male	NOUN
gra-1905	91	18	(	(	PUNCT
gra-1905	91	19	31.1	31.1	NUM
gra-1905	91	20	%	%	NOUN
gra-1905	91	21	)	)	PUNCT
gra-1905	91	22	.	.	PUNCT
gra-1905	92	1	overall	overall	ADJ
gra-1905	92	2	38.8	38.8	NUM
gra-1905	92	3	%	%	NOUN
gra-1905	92	4	patients	patient	NOUN
gra-1905	92	5	had	have	AUX
gra-1905	92	6	raised	raise	VERB
gra-1905	92	7	fbs	fbs	PROPN
gra-1905	92	8	or	or	CCONJ
gra-1905	92	9	on	on	ADP
gra-1905	92	10	antidiabetic	antidiabetic	ADJ
gra-1905	92	11	drugs	drug	NOUN
gra-1905	92	12	previously	previously	ADV
gra-1905	92	13	.	.	PUNCT
gra-1905	93	1	(	(	PUNCT
gra-1905	93	2	table-1	table-1	NUM
gra-1905	93	3	)	)	PUNCT
gra-1905	93	4	gold	gold	NOUN
gra-1905	93	5	stage	stage	NOUN
gra-1905	93	6	total	total	ADJ
gra-1905	93	7	patients	patient	NOUN
gra-1905	93	8	metabolic	metabolic	NOUN
gra-1905	93	9	syndrome	syndrome	PROPN
gra-1905	93	10	total	total	NOUN
gra-1905	93	11	i	i	NOUN
gra-1905	93	12	5	5	NUM
gra-1905	93	13	male	male	NOUN
gra-1905	93	14	3	3	NUM
gra-1905	93	15	1	1	NUM
gra-1905	93	16	2(40	2(40	NUM
gra-1905	93	17	%	%	NOUN
gra-1905	93	18	)	)	PUNCT
gra-1905	93	19	female	female	ADJ
gra-1905	93	20	2	2	NUM
gra-1905	93	21	1	1	NUM
gra-1905	93	22	ii	ii	NUM
gra-1905	93	23	17	17	NUM
gra-1905	93	24	male	male	NOUN
gra-1905	93	25	14	14	NUM
gra-1905	93	26	6	6	NUM
gra-1905	93	27	8(47.06	8(47.06	NUM
gra-1905	93	28	%	%	NOUN
gra-1905	93	29	)	)	PUNCT
gra-1905	93	30	female	female	ADJ
gra-1905	93	31	3	3	NUM
gra-1905	93	32	2	2	NUM
gra-1905	93	33	iii	iii	NUM
gra-1905	93	34	35	35	NUM
gra-1905	93	35	male	male	NOUN
gra-1905	93	36	22	22	NUM
gra-1905	93	37	4	4	NUM
gra-1905	93	38	9(25.71	9(25.71	NUM
gra-1905	93	39	%	%	NOUN
gra-1905	93	40	)	)	PUNCT
gra-1905	93	41	1(10	1(10	NUM
gra-1905	93	42	%	%	NOUN
gra-1905	93	43	)	)	PUNCT
gra-1905	93	44	female	female	NOUN
gra-1905	93	45	13	13	NUM
gra-1905	93	46	5	5	NUM
gra-1905	93	47	iv	iv	NUM
gra-1905	93	48	10	10	NUM
gra-1905	93	49	male	male	NOUN
gra-1905	93	50	6	6	NUM
gra-1905	93	51	0	0	NUM
gra-1905	93	52	female	female	ADJ
gra-1905	93	53	4	4	NUM
gra-1905	93	54	1	1	NUM
gra-1905	93	55	total	total	NOUN
gra-1905	93	56	67(100	67(100	NOUN
gra-1905	93	57	%	%	NOUN
gra-1905	93	58	)	)	PUNCT
gra-1905	94	1	20(29.85	20(29.85	NUM
gra-1905	94	2	%	%	NOUN
gra-1905	94	3	)	)	PUNCT